
<html lang="en"     class="pb-page"  data-request-id="d2777782-d97a-4565-b664-38a57f6d33ec"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00002;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain" /></meta><meta name="dc.Creator" content="Kouki  Fuchino" /></meta><meta name="dc.Creator" content="Yasunori  Mitsuoka" /></meta><meta name="dc.Creator" content="Moriyasu  Masui" /></meta><meta name="dc.Creator" content="Noriyuki  Kurose" /></meta><meta name="dc.Creator" content="Shuhei  Yoshida" /></meta><meta name="dc.Creator" content="Kazuo  Komano" /></meta><meta name="dc.Creator" content="Takahiko  Yamamoto" /></meta><meta name="dc.Creator" content="Masayoshi  Ogawa" /></meta><meta name="dc.Creator" content="Chie  Unemura" /></meta><meta name="dc.Creator" content="Motoko  Hosono" /></meta><meta name="dc.Creator" content="Hisanori  Ito" /></meta><meta name="dc.Creator" content="Gaku  Sakaguchi" /></meta><meta name="dc.Creator" content="Shigeru  Ando" /></meta><meta name="dc.Creator" content="Shuichi  Ohnishi" /></meta><meta name="dc.Creator" content="Yasuto  Kido" /></meta><meta name="dc.Creator" content="Tamio  Fukushima" /></meta><meta name="dc.Creator" content="Hirofumi  Miyajima" /></meta><meta name="dc.Creator" content="Shuichi  Hiroyama" /></meta><meta name="dc.Creator" content="Kiyotaka  Koyabu" /></meta><meta name="dc.Creator" content="Deborah  Dhuyvetter" /></meta><meta name="dc.Creator" content="Herman  Borghys" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Creator" content="Yoshinori  Yamano" /></meta><meta name="dc.Creator" content="Yasuyoshi  Iso" /></meta><meta name="dc.Creator" content="Ken-ichi  Kusakabe" /></meta><meta name="dc.Description" content="Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key enzyme responsible for producing Aβ p..." /></meta><meta name="Description" content="Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key enzyme responsible for producing Aβ p..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 7, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00002" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00002" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00002" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00002" /></link>
        
    
    

<title>Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00002" /></meta><meta property="og:title" content="Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0013.jpeg" /></meta><meta property="og:description" content="Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD. Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration. Starting from a 1,3-dihydrooxazine lead 6 identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of 15 that produced significant Aβ reduction with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models. This compound improved the brain-to-plasma ratio relative to 6 by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00002"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00002">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00002&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00002&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00002&amp;href=/doi/10.1021/acs.jmedchem.8b00002" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5122-5137</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01457" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01709" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kouki Fuchino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kouki Fuchino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kouki++Fuchino">Kouki Fuchino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasunori Mitsuoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasunori Mitsuoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasunori++Mitsuoka">Yasunori Mitsuoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moriyasu Masui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moriyasu Masui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Moriyasu++Masui">Moriyasu Masui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noriyuki Kurose</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noriyuki Kurose</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noriyuki++Kurose">Noriyuki Kurose</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuhei Yoshida</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuhei Yoshida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuhei++Yoshida">Shuhei Yoshida</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazuo Komano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuo Komano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuo++Komano">Kazuo Komano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takahiko Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takahiko Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takahiko++Yamamoto">Takahiko Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Masayoshi Ogawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masayoshi Ogawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masayoshi++Ogawa">Masayoshi Ogawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chie Unemura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chie Unemura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chie++Unemura">Chie Unemura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Motoko Hosono</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Motoko Hosono</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Motoko++Hosono">Motoko Hosono</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hisanori Ito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hisanori Ito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hisanori++Ito">Hisanori Ito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gaku Sakaguchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gaku Sakaguchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gaku++Sakaguchi">Gaku Sakaguchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shigeru Ando</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shigeru Ando</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shigeru++Ando">Shigeru Ando</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuichi Ohnishi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuichi Ohnishi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuichi++Ohnishi">Shuichi Ohnishi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuto Kido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuto Kido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuto++Kido">Yasuto Kido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tamio Fukushima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tamio Fukushima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tamio++Fukushima">Tamio Fukushima</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hirofumi Miyajima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hirofumi Miyajima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hirofumi++Miyajima">Hirofumi Miyajima</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuichi Hiroyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuichi Hiroyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuichi++Hiroyama">Shuichi Hiroyama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kiyotaka Koyabu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kiyotaka Koyabu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kiyotaka++Koyabu">Kiyotaka Koyabu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah Dhuyvetter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah Dhuyvetter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Dhuyvetter">Deborah Dhuyvetter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Herman Borghys</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Herman Borghys</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Borghys">Herman Borghys</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harrie J. M. Gijsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harrie J. M. Gijsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoshinori Yamano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshinori Yamano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshinori++Yamano">Yoshinori Yamano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuyoshi Iso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuyoshi Iso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuyoshi++Iso">Yasuyoshi Iso</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ken-ichi Kusakabe</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ken-ichi Kusakabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +81-6-6331-6190. Fax: +81-6-6332-6385. E-mail: <a href="/cdn-cgi/l/email-protection#98f3fdf6b5f1fbf0f1b6f3edebf9f3f9fafdd8ebf0f1f7f6f7fff1b6fbf7b6f2e8"><span class="__cf_email__" data-cfemail="610a040f4c080209084f0a1412000a000304211209080e0f0e06084f020e4f0b11">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ken-ichi++Kusakabe">Ken-ichi Kusakabe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00002&amp;href=/doi/10.1021%2Facs.jmedchem.8b00002" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5122–5137</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 7, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 January 2018</li><li><span class="item_label"><b>Published</b> online</span>7 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00002</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5122%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKouki%2BFuchino%252C%2BYasunori%2BMitsuoka%252C%2BMoriyasu%2BMasui%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b00002%26title%3DRational%2BDesign%2Bof%2BNovel%2B1%252C3-Oxazine%2BBased%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitors%253A%2BIncorporation%2Bof%2Ba%2BDouble%2BBond%2BTo%2BReduce%2BP-gp%2BEfflux%2BLeading%2Bto%2BRobust%2BA%25CE%25B2%2BReduction%2Bin%2Bthe%2BBrain%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5137%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00002"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2454</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00002" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kouki&quot;,&quot;last_name&quot;:&quot;Fuchino&quot;},{&quot;first_name&quot;:&quot;Yasunori&quot;,&quot;last_name&quot;:&quot;Mitsuoka&quot;},{&quot;first_name&quot;:&quot;Moriyasu&quot;,&quot;last_name&quot;:&quot;Masui&quot;},{&quot;first_name&quot;:&quot;Noriyuki&quot;,&quot;last_name&quot;:&quot;Kurose&quot;},{&quot;first_name&quot;:&quot;Shuhei&quot;,&quot;last_name&quot;:&quot;Yoshida&quot;},{&quot;first_name&quot;:&quot;Kazuo&quot;,&quot;last_name&quot;:&quot;Komano&quot;},{&quot;first_name&quot;:&quot;Takahiko&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Masayoshi&quot;,&quot;last_name&quot;:&quot;Ogawa&quot;},{&quot;first_name&quot;:&quot;Chie&quot;,&quot;last_name&quot;:&quot;Unemura&quot;},{&quot;first_name&quot;:&quot;Motoko&quot;,&quot;last_name&quot;:&quot;Hosono&quot;},{&quot;first_name&quot;:&quot;Hisanori&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Gaku&quot;,&quot;last_name&quot;:&quot;Sakaguchi&quot;},{&quot;first_name&quot;:&quot;Shigeru&quot;,&quot;last_name&quot;:&quot;Ando&quot;},{&quot;first_name&quot;:&quot;Shuichi&quot;,&quot;last_name&quot;:&quot;Ohnishi&quot;},{&quot;first_name&quot;:&quot;Yasuto&quot;,&quot;last_name&quot;:&quot;Kido&quot;},{&quot;first_name&quot;:&quot;Tamio&quot;,&quot;last_name&quot;:&quot;Fukushima&quot;},{&quot;first_name&quot;:&quot;Hirofumi&quot;,&quot;last_name&quot;:&quot;Miyajima&quot;},{&quot;first_name&quot;:&quot;Shuichi&quot;,&quot;last_name&quot;:&quot;Hiroyama&quot;},{&quot;first_name&quot;:&quot;Kiyotaka&quot;,&quot;last_name&quot;:&quot;Koyabu&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Dhuyvetter&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Borghys&quot;},{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;},{&quot;first_name&quot;:&quot;Yoshinori&quot;,&quot;last_name&quot;:&quot;Yamano&quot;},{&quot;first_name&quot;:&quot;Yasuyoshi&quot;,&quot;last_name&quot;:&quot;Iso&quot;},{&quot;first_name&quot;:&quot;Ken-ichi&quot;,&quot;last_name&quot;:&quot;Kusakabe&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5122-5137&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00002&quot;},&quot;abstract&quot;:&quot;Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD. Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration. Starting from a 1,3-dihydrooxazine lead 6 identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of 15 that produced significant Aβ reduction with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models. This compound improved the brain-to-plasma ratio relative to 6 by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00002&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00002" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00002&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00002" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00002&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00002" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00002&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00002&amp;href=/doi/10.1021/acs.jmedchem.8b00002" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00002" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00002" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26pmid%3D29733614%26genre%3Darticle%26aulast%3DFuchino%26date%3D2018%26atitle%3DRational%2BDesign%2Bof%2BNovel%2B1%252C3-Oxazine%2BBased%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitors%253A%2BIncorporation%2Bof%2Ba%2BDouble%2BBond%2BTo%2BReduce%2BP-gp%2BEfflux%2BLeading%2Bto%2BRobust%2BA%25CE%25B2%2BReduction%2Bin%2Bthe%2BBrain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5122%26epage%3D5137%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD. Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration. Starting from a 1,3-dihydrooxazine lead <b>6</b> identified by a hit-to-lead SAR following HTS, we adopted a p<i>K</i><sub>a</sub> lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of <b>15</b> that produced significant Aβ reduction with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models. This compound improved the brain-to-plasma ratio relative to <b>6</b> by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common type of dementia. The histopathological hallmarks of AD are neurofibrillary tangles, aggregated and hyperphosphorylated tau proteins, and amyloid plaques composed of amyloid β (Aβ) peptides of 38–43 amino acids. Patients with AD die within 3–9 years after diagnosis. In addition to shortening of life expectancy, AD has a significant impact on quality of life for the patients and their family caregivers. In 2015, over 46 million people were living with dementia worldwide, with AD being the most common form, and the number is estimated to increase to 132 million by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Dementia imposes an enormous economic burden with the total estimated worldwide cost of 818 billion dollars, and the estimated cost for 2018 is a trillion dollars.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In spite of these serious issues, the standard therapy of donepezil and memantine only temporarily relieves disease symptoms. The development of disease-modifying drugs has thus far been unsuccessful.</div><div class="NLM_p">Strategies targeting inhibition of Aβ peptide production should be important for disease-modification of AD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The β-site amyloid precursor protein cleaving enzyme 1 (BACE1), also known as β-secretase or memapsin 2, is an aspartic protease and the rate-limiting enzyme in the Aβ peptide production.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> First, the amyloid precursor protein (APP) is cleaved by BACE1 to generate the N-terminus of sAPPβ and the membrane-bound C-terminus of C99. Second, C99 is cleaved by γ-secretase to generate the C-terminus of the Aβ peptides including various isoforms of 38–43 amino acid length, of which the Aβ42 consisting of 42 amino acids is the most toxic form as it readily aggregates to generate toxic oligomers,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> which ultimately result in the deposition of amyloid plaques. Although γ-secretase is also considered to be a promising target for reducing Aβ production, its concomitant inhibition of Notch processing has hampered the development of γ-secretase inhibitors for clinical use.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> BACE1 knockout mice are viable and exhibit a moderate phenotype of morphologic and functional deficit,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> while deletion of the PSEN-1 gene, the catalytic site of γ-secretase, is embryonically lethal, making BACE1 a more attractive target for Aβ-lowering therapeutics.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Mutations found in APP also provide genetic evidence for the importance of BACE1 in AD. For example, the Swedish mutation (K670N and M671L) is found near the BACE1 cleavage site and makes APP more susceptible to cleavage by BACE1, which ultimately causes familial AD (FAD).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In contrast, the A673T mutation is less effectively cleaved by BACE1 and results in an approximately 40% reduction in Aβ peptide formation leading to a protective effect against AD.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3,7)</a> Such evidence partly demonstrates the clinical proof of concept by inhibition of BACE1.</div><div class="NLM_p">Significant efforts have been directed at exploring orally available and brain penetrant BACE1 inhibitors since the identification of BACE1 in 1999.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Initial BACE1 inhibitors were designed based on the transition state or other aspartic proteases such as HIV protease and renin. However, these efforts failed to identify brain penetrant inhibitors with significant in vivo efficacy. Their high molecular weight, polar surface area, and rotatable bond number resulted in compounds with low permeability and high P-gp efflux, which ultimately limited CNS exposure. Identifying small molecules and nonpeptidomimetic BACE1 inhibitors was considered to be very challenging due to the large size of the catalytic site in BACE1.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The first examples of potent and non-peptide inhibitors with amidine-based scaffolds were reported by scientists at Schering-Plough and Wyeth.<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8,10)</a> Since their discovery, many pharmaceutical companies pursued analogs. Although early amidine-based inhibitors retaining high P-gp efflux had low potency in vivo, the challenge was addressed successfully by utilizing structure-based design and controlling physicochemical properties, leading to compounds with robust Aβ reduction in preclinical animal models.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Finally, minimizing the risks associated with the high basicity and lipophilicity observed with these analogs, such as high hERG activity and CYP2D6 inhibition, culminated in the discovery of clinical BACE1 inhibitors including <b>1</b> (LY-2811376),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> LY-2886721,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>2</b> (MK-8931, verubecestat),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><b>3</b> (E-2609, elenbecestat),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> RG-7129,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> lanabecestat (AZD-3293),<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> CNP520,<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> and JNJ-54861911<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). Unfortunately, phase I/II studies of several of these compounds were discontinued, most likely due to off-target toxicity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Therefore, identifying BACE1 inhibitors in diverse structural classes was considered to be worthwhile.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Amidine-Based Clinical BACE1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2003, our early research started with a high-throughput screening (HTS) campaign utilizing a cellular Aβ production assay, which successfully identified a thiazine-based hit compound <b>4</b> without cellular toxicity (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>). Our early efforts revealed that incorporation of amide groups on the phenyl ring in <b>4</b> significantly improved potency leading to the discovery of <b>5</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Furthermore, replacement of the sulfur in <b>5</b> with an oxygen atom followed by an amide screen led to <b>6</b>, which exhibited comparable cellular potency, while reduced activity was observed in the biochemical assay relative to <b>5</b>. In parallel with our efforts, Roche also identified the same hit compound of <b>4</b> in their HTS campaign.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Their efforts utilizing fluorine scans by reducing basicity (p<i>K</i><sub>a</sub>) on amidine moieties culminated in the CF<sub>3</sub>-substitued dihydrooxazine <b>7</b> with in vivo efficacy (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In spite of the excellent profile described for <b>7</b>, the Roche clinical compound RG-7129, an analog of <b>7</b>, was terminated in phase I.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. HTS Hit <b>4</b> and Initial Leads <b>5</b> and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. BACE1 Inhibitors <b>7</b>, <b>8</b>, and <b>9</b> Identified Utilizing a p<i>K</i><sub>a</sub>-Lowering Strategy</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Controlling p<i>K</i><sub>a</sub> is a well-known approach for reducing P-gp efflux as well as mitigating hERG inhibitory activity,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> particularly in exploring BACE1 inhibitors as with compounds <b>7</b>, <b>8</b>, and <b>9</b> (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>).<a onclick="showRef(event, 'cit9h ref21 ref24'); return false;" href="javascript:void(0);" class="ref cit9h ref21 ref24">(9h,21,24)</a> For instance, to lower the p<i>K</i><sub>a</sub> of amidine or amine moieties that interact with the catalytic aspartates in BACE1, incorporation of electron withdrawing groups such as fluorine, oxygen, carbonyl, and sulfone has been successfully applied.<a onclick="showRef(event, 'ref13 ref20 ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref13 ref20 ref21 ref24">(13,20,21,24)</a> Our aim in this work was to improve the P-gp and the hERG liabilities observed with <b>6</b> by lowering the p<i>K</i><sub>a</sub>. We describe an alternative approach to reducing the p<i>K</i><sub>a</sub> of the dihydrooxazine <b>6</b> by incorporating a double bond, which successfully lowered the p<i>K</i><sub>a</sub> by 2 log units, leading to oxazine <b>11</b> with reduced P-gp efflux. Further modification by fine-tuning the p<i>K</i><sub>a</sub> led to the discovery of compound <b>15</b> that showed robust Aβ reduction in mouse and dog, as well as good cardiovascular safety margins in guinea pig and dog over the efficacy level (EC<sub>50</sub>) in dog.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Design of Novel 1,3-Oxazine BACE1 Inhibitors by Incorporating a Double Bond</h3><div class="NLM_p">The initial lead <b>6</b> displayed moderate to good Aβ inhibitory activity in cells (IC<sub>50</sub> = 3.7 nM); however, it exhibited a high P-gp efflux ratio of 36 in MDCK cells resulting in a low total brain-to-plasma ratio (<i>B</i>/<i>P</i> or <i>K</i><sub>p</sub>) of 0.29 as well as a hERG inhibitory activity of 78% at 5 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Such profiles resulted in a lack of significant Aβ reduction in mouse at 10 mg/kg and could raise cardiovascular concerns if used clinically. Therefore, we initiated our efforts to improve the P-gp and hERG values in order to obtain centrally active BACE1 inhibitors with acceptable cardiovascular safety.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Exploration of the Oxazine Head Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values represent the mean values of at least two determinations.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Biochemical homogeneous time-resolved fluorescence (HTRF)-based assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of secreted Aβ40 in human APP-transfected human neuroblastoma (SH-SY5Y) cells via an HTRF-based assay.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Efflux ratio measured in MDCK cells transfected with human MDR1 at absorption systems.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">% inhibition at 5 μM measured in HEK293 or CHO cells transfected with hERG channels using an automated patch clamp system.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">log <i>D</i> determined in 1-octanol/phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">p<i>K</i><sub>a</sub> determined by capillary electrophoresis (CE).</p></div></div><div></div></div><div class="NLM_p">For central nervous system (CNS) drugs, optimal p<i>K</i><sub>a</sub> ranges of basic amines (the conjugate acids of amines), such as 7.5 < p<i>K</i><sub>a</sub> < 10.5 or p<i>K</i><sub>a</sub> < 8, were proposed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> According to these analyses, lowering p<i>K</i><sub>a</sub> achieved a decreased likelihood of P-gp recognition and hERG inhibition, while the lower limits were estimated based on data sets including compounds targeting monoamine receptors or transporters.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Considering this, we decided it would be important to determine the lower limit of p<i>K</i><sub>a</sub> utilizing BACE1 inhibitors alone, due to the difference in optimal p<i>K</i><sub>a</sub> ranges for retaining potency among these targets. Indeed, amine protonation is critical for inhibiting BACE1 enzyme at a given pH in the assay. Our BACE1 biochemical assay was conducted at pH 5.0, while our cellular assay was at the physiological pH of 7.4. Because the cellular potency reflects Aβ reduction in vivo, understanding the lower limit of amidine p<i>K</i><sub>a</sub> in our cellular assay was important for designing BACE1 inhibitors. For the analysis, we utilized our proprietary BACE1 inhibitors at that time, most of which included thiazine derivatives reported previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A good correlation between biochemical and cellular IC<sub>50</sub> values was observed except for compounds with a p<i>K</i><sub>a</sub> < 6.5 and a biochemical IC<sub>50</sub> < 100 nM. The discrepancy came from the difference in pH used in our biochemical and cellular assays of 5.0 and 7.4, respectively. A box plot analysis using compounds with a biochemical IC<sub>50</sub> < 100 nM clearly indicated that compounds with a p<i>K</i><sub>a</sub> < 6.5 reduced the cellular activities regardless of having good biochemical potency data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf" class="ext-link">Supporting Information, Figure S1</a>). Given that P-gp and the hERG channel recognize the ionization state at the physiological pH of 7.4, the optimal upper limit was considered to be 7.4. The analysis and hypothesis led to a proposed guideline of 6.5 < p<i>K</i><sub>a</sub> < 7.4 for our research.</div><div class="NLM_p">To develop BACE1 inhibitors meeting our p<i>K</i><sub>a</sub> guideline, we designed the oxazine head group <b>B</b> inserting a double bond into the dihydrooxazine head group <b>A</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Because good alignment between the measured and ACD predicted p<i>K</i><sub>a</sub> values in <b>A</b> was observed, we utilized ACD software to predict the p<i>K</i><sub>a</sub> of <b>B</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The result was an acceptable value of 7.0, most likely due to delocalization of the lone pairs on the nitrogen atoms, which initiated our efforts to synthesize the oxazine analogs.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of novel oxazine <b>B</b> from dihydrooxazine <b>A</b>. <sup><i>a</i></sup>The p<i>K</i><sub>a</sub> values were calculated with ACD/Percepta as the imine tautomer.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimization of the 1,3-Oxazine Head Group</h3><div class="NLM_p">The designed compound <b>11</b> showed a reduced p<i>K</i><sub>a</sub> of 7.7 (Δp<i>K</i><sub>a</sub> of 2.1 over <b>6</b>) and an attenuated P-gp efflux ratio of 7.5 while exhibiting a slightly increased hERG inhibitory activity, 2-fold decrease in potency in the biochemical and cellular assays, and a significantly increased log <i>D</i> when compared with <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Additionally, we observed a discrepancy between the measured and predicted p<i>K</i><sub>a</sub> values (7.7 vs 7.0) lying outside the range of the guideline for p<i>K</i><sub>a</sub>. To mitigate hERG inhibitory activity as well as improve potency, we investigated the incorporation of substituents on the double bond in <b>11</b>. Compound <b>13</b>, possessing a methyl group at the 6-position, was 3 times more potent than <b>11</b> in the biochemical assay, while moving the methyl group to the 5-position led to <b>12</b> with reduced potency, indicating that the 6-methyloxazine <b>13</b> could serve as a key scaffold for fine-tuning the p<i>K</i><sub>a</sub> to within the optimal range. To further reduce the p<i>K</i><sub>a</sub>, we incorporated a fluorine atom at the 4-methyl group, leading to compound <b>14</b> with improved hERG liability. However, despite biochemical activity comparable to <b>13</b>, decreased cellular potency was observed. This result can be explained by the p<i>K</i><sub>a</sub> of 6.3, which violates the lower limit of our analysis. Alternatively, substitution of the 6-methyl group in <b>13</b> with a fluorine led to compound <b>15</b> with an optimal p<i>K</i><sub>a</sub> of 6.9, which retained the potency associated with slightly reduced hERG inhibition relative to the 6-methyl <b>13</b>. Replacement of the 4-methyl group with a cycloplopyl group (<b>16</b>) was not tolerated. Incorporation of methoxy as an alternative electron withdrawing group (<b>17</b>) led to a p<i>K</i><sub>a</sub> of 7.4. Although <b>17</b> had a p<i>K</i><sub>a</sub> value in the acceptable range, it showed reduced cellular potency and was found to be a strong P-gp substrate. On the other hand, its hERG potency was better than the fluorine analog <b>15</b> despite its higher p<i>K</i><sub>a</sub>. Although both the fluorine in <b>15</b> and the methoxy in <b>17</b> function as electron-withdrawing groups, the difference in hydrogen bonding capacity and lipophilicity between <b>15</b> and <b>17</b> can explain these discrepancies. The methoxy in <b>17</b> may have a favorable interaction with P-gp relative to the fluorine in <b>15</b>, most likely because of its hydrogen bond accepting feature; in contrast, the more lipophilic fluorine in <b>15</b> may have better affinity for the hERG channel than the methoxy in <b>17</b>. Introduction of an additional fluorine in <b>15</b> led to 6-difluoromethyl <b>18</b> with a p<i>K</i><sub>a</sub> of 6.4. Like compound <b>14</b>, its reduced p<i>K</i><sub>a</sub> was associated with impaired cellular potency. Consistent with the above analysis, such a low p<i>K</i><sub>a</sub> value was translated into improvements in P-gp and hERG levels. Except for <b>18</b> with a lower p<i>K</i><sub>a</sub> of 6.5, the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were more potent in the cellular assay than in the biochemical assay. This could be explained by accumulation of basic inhibitors in the acidic endosomes, where BACE1 resides and colocalizes with APP,<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> and the pH is maintained in a range of 4.5–6.5.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The rat pharmacokinetic (PK) profiles of selected analogs <b>6</b>, <b>14</b>, <b>15</b>, and <b>17</b> using our preliminary screening model (cassette dosing, <i>n</i> = 2) were assessed (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The initial lead <b>6</b> was stable in rat liver microsomes (RLM), while a high fraction unbound in rat serum (<i>f</i><sub>u,s</sub> in rat) of 0.41 resulted in a moderate to high clearance of 37 mL min<sup>–1</sup> kg<sup>–1</sup>. Although <b>6</b> had a high Vd<sub>ss</sub> of 6.1 L/kg, a low total brain-to-plasma (<i>B</i>/<i>P</i>) ratio of 0.29 and an unbound brain-to-plasma ratio (<i>K</i><sub>p,uu</sub>) of 0.057 were observed. Compounds <b>14</b> and <b>15</b> with reduced p<i>K</i><sub>a</sub> values exhibited improved <i>B</i>/<i>P</i> ratios of 1.30 and 0.90 (<i>K</i><sub>p,uu</sub> values of 0.52 and 0.37), respectively, which can be explained by their reduced P-gp efflux ratios. Likewise, the reduced brain penetration of the methoxy analog <b>17</b> (<i>B</i>/<i>P</i> = 0.19) can be attributed to its high P-gp efflux. Despite their varied metabolic stability in RLM, all the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> had favorable oral exposures. Taken together, 6-fluoromethyl <b>15</b> was notable in that it displayed a pronounced improvement in P-gp efflux resulting in a good <i>B</i>/<i>P</i> ratio as well as retaining cellular potency, although the hERG potency still required further mitigation.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Properties of Compounds <b>6</b>, <b>14</b>, <b>15</b>, and <b>17</b> in Sprague-Dawley Rat Using a Cassette Method</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat, iv, 0.5 mg/kg, <i>n</i> = 2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">rat, po, 1 mg/kg, <i>n</i> = 2<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">RLM (%)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,s</sub>/<i>f</i><sub>u,b</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char="."><i>B/P</i><a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t2fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng·h/mL)<a class="ref internalNav" href="#t2fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#t2fn10" aria-label="j">j</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t2fn11" aria-label="k">k</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="left">0.41/0.080</td><td class="colsep0 rowsep0" align="char" char=".">37.2</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="left">0.057</td><td class="colsep0 rowsep0" align="char" char=".">328</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left">0.14/0.056</td><td class="colsep0 rowsep0" align="char" char=".">20.6</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="left">0.16/0.066</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">0.90</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="char" char=".">617</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="left">0.13/NT</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">892</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Dosed as a solution of test compounds in <i>N</i>,<i>N</i>-dimethylacetamide (DMA)/propylene glycol (PG) = 1/1.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Dosed as a suspension of test compounds in 0.5% methylcellulose (MC, 400 cP).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">% remaining in rat liver microsomes after 30 min incubation.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last"><i>f</i><sub>u,s</sub> = fraction unbound in rat serum. <i>f</i><sub>u,b</sub> = fraction unbound in rat brain. NT = not tested.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Total clearance.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Total brain-to-plasma ratio measured at 0.5 h.</p></div><div class="footnote" id="t2fn8"><sup><sup>h</sup></sup><p class="last">Unbound brain-to-plasma ratio measured at 0.5 h. ND = not determined.</p></div><div class="footnote" id="t2fn9"><sup><sup>i</sup></sup><p class="last">Plasma area under the concentration–time curve.</p></div><div class="footnote" id="t2fn10"><sup><sup>j</sup></sup><p class="last">Maximal plasma concentration.</p></div><div class="footnote" id="t2fn11"><sup><sup>k</sup></sup><p class="last">Oral bioavailability.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Optimization of the Tail Group in <b>15</b></h3><div class="NLM_p">In an effort to improve the hERG inhibitory activity of <b>15</b>, we focused on optimizing the tail group of R (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition to its suboptimal hERG profile, <b>15</b> was found to be somewhat unstable in rat plasma, relative to other compounds synthesized at our laboratory. Although this instability may be limited to the rat due to the highly expressed profile of carboxylesterases (CES) in the plasma compared to non-rodents,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> we first investigated compounds with substituents at the <i>ortho</i>-position of the amide group such as <b>20</b>, <b>21</b>, and <b>22</b>, in order to prevent hydrolysis by CES. As expected, these compounds were found to improve rat plasma <i>t</i><sub>1/2</sub> to more than 50 h. Interestingly, incorporating the <i>ortho</i>-substituents also reduced the hERG inhibitory activity relative to <b>15</b>, particularly in <i>ortho</i>-chloro <b>21</b> and <i>ortho</i>-methoxy <b>22</b> (30% and 22% inhibition, respectively), while exhibiting an increased P-gp efflux which would lead to reduced brain penetration. Although the methyl <b>20</b> provided reduced hERG inhibition (50%) and a reasonable <i>B</i>/<i>P</i> ratio (0.62), decreased human liver microsomal (HLM) stability was observed compared to <b>15</b> (63% vs 88% remaining).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exploration of the Oxazine Head Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0011.gif" alt="" id="GRAPHIC-d176e1579-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0012.gif" alt="" id="GRAPHIC-d176e1580-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values represent the mean values of at least two determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Biochemical homogeneous time-resolved fluorescence (HTRF)-based assay.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of secreted Aβ40 in human APP-transfected human neuroblastoma (SH-SY5Y) cells via an HTRF-based assay.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Efflux ratio measured in MDCK cells transfected with human MDR1 at absorption systems.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">% inhibition at 5 μM measured in CHO cells transfected with hERG channels using an automated patch clamp system.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">% remaining after 30 min incubation with rat liver (RLM) and human liver microsomes (HLM).</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Sprague-Dawley rats.</p></div><div class="footnote" id="t3fn8"><sup><sup>h</sup></sup><p class="last">Total clearance dosed iv at 0.5 mg/kg as a solution in DMA/PG = 1/1 (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn9"><sup><sup>i</sup></sup><p class="last">Plasma half-life in vitro.</p></div><div class="footnote" id="t3fn10"><sup><sup>j</sup></sup><p class="last">Total brain-to-plasma ratio determined by iv dose at 0.5 h.</p></div><div class="footnote" id="t3fn11"><sup><sup>k</sup></sup><p class="last">log <i>D</i> determined in 1-octanol/phosphate buffer at pH 7.4.</p></div></div><div></div></div><div class="NLM_p last">For further improvements in hERG as well as retaining acceptable ADMET profiles, a variety of six-membered heterocycles was explored. Among them, pyrazine derivatives such as <b>23</b>–<b>26</b> were found to reduce hERG inhibitory activity. Although the methoxypyrazine <b>23</b> had a reduced hERG inhibition of 30% at 5 μM, it was associated with decreased plasma stability (<i>t</i><sub>1/2</sub> of 14.3 h) and poor RLM stability (13% remaining after 30 min) resulting in a high CL value of 64.9 mL min<sup>–1</sup> kg<sup>–1</sup>. Replacement of the methoxy group in <b>23</b> with difluoromethyl (<b>24</b>) or fluoromethoxy (<b>25</b>) provided molecules with improved RLM stability (44% and 52% remaining after 30 min, respectively), while these were still unstable in rat plasma (plasma <i>t</i><sub>1/2</sub> = 9.2 and 10.5 h, respectively). Furthermore, such analogs (<b>23</b>–<b>25</b>) displayed only modest potency in biochemical and cellular assays (cellular IC<sub>50</sub> = 22 nM, 72 nM, and 31 nM, respectively). To mitigate these problems observed with the pyrazine tails, a small set of substituents, such as methyl (data not shown), methoxy (data not shown), and amino, was incorporated on the pyrazine in <b>25</b> at the <i>ortho</i>-position of the amide group leading to aminopyrazine <b>26</b>. Indeed, <b>26</b> was 5-fold more potent than the corresponding non-amino <b>25</b> (cellular IC<sub>50</sub> of 6.6 nM in <b>26</b>), and plasma stability was also improved relative to the nonsubstituted <b>23</b>, <b>24</b>, and <b>25</b> but was comparable to the cyanopyridine <b>15</b> (plasma <i>t</i><sub>1/2</sub> of 22.3 h in <b>26</b>). Despite addition of the polar amino group, an increased log <i>D</i> was unexpectedly observed for <b>26</b> in comparison to the non-amino <b>25</b>, resulting in reduced metabolic stability in RLM and HLM (35% and 67% remaining after 30 min, respectively). However, although introduction of NH<sub>2</sub> increased the hydrogen bond count, <b>26</b> provided a comparable P-gp efflux to the non-amino <b>25</b>, very likely due to the intramolecular hydrogen bond of the amide carbonyl with the NH<sub>2</sub>. We postulated that the improved potency observed in <b>26</b> might come from the increased planarity between the amide and the pyrazine ring derived from the intramolecular hydrogen bond of the carbonyl with the amino group. Therefore, we hypothesized that reducing the ring size, which can maintain planarity and decrease lipophilicity, could lead to retaining potency as well as improving metabolic stability. Indeed, compounds with an oxazole ring such as <b>27</b> and <b>28</b> had a comparable cellular activity to the aminopyriazine <b>26</b>. Like the pyrazines, changes to the isoxazoles retained the low hERG inhibitory potential. Unfortunately, despite their reduced log <i>D</i> values relative to <b>26</b>, the isoxazoles <b>27</b> and <b>28</b> still displayed suboptimal metabolic stability in RLM (57% and 39% remaining after 30 min, respectively). Furthermore, this modification was associated with increased P-gp recognition resulting in poor brain penetration. In the end, although the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> did lower hERG inhibition compared to cyanopyridine <b>15</b>, the improvement came at the cost of reduced potency, low metabolic stability, or high P-gp recognition. The balanced profile of <b>15</b> led to its being subjected to further study.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cocrystal Structure of <b>15</b> Bound to BACE1</h3><div class="NLM_p">The X-ray structure of <b>15</b> complexed with human BACE1 was determined at a resolution of 2.30 Å (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compound <b>15</b> binds to a flap-closed BACE1 structure, in which the Tyr71 side chain hydroxyl on the flap forms a hydrogen-bond interaction with the NH of the Trp76 side chain. Like other amidine-based inhibitors,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> the amidine moiety of <b>15</b> interacts with the two catalytic aspartate residues 32 and 228. The two aromatic rings of the fluorophenyl and the cyanopyridine occupy the S1 and S3 pockets of the enzyme, respectively. In addition, the fluorine on the phenyl forms a van der Waals contact with the side chain of Tyr71. Indeed, the corresponding non-fluorine analog was 2–3 times less potent than <b>15</b> in the biochemical assay (data not shown) indicating the importance of the fluorine. Finally, the amide NH hydrogen forms a hydrogen bond with the backbone carbonyl oxygen of Gly230 as well as with the pyridine nitrogen in <b>15</b>.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of the oxazine <b>15</b> bound to the active site of human BACE1 determined at 2.30 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY">5YGY</a>). Purple mesh shows |<i>F</i><sub>o</sub>| – |<i>F</i><sub>c</sub>| map contoured at 2.0σ in which ligand coordinates are omitted from the calculation. Key residues of the catalytic residues Asp228 and Asp32 (green), Tyr71 (purple) on the Flap region, and Gly230 (gray) are shown in stick style. Compound <b>15</b> is shown in ball-and-stick style with carbon atoms colored yellow. Nitrogen, oxygen, and fluorine atoms are colored blue, red, and sky blue, respectively. Dashed lines represent hydrogen bond interactions between <b>15</b> and BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro ADMET Profiles of <b>15</b></h3><div class="NLM_p last">The free base of compound <b>15</b> formed a crystalline powder that had good aqueous thermodynamic solubility of 3220 μg/mL and 28.7 μg/mL at pH 1.2 and 6.8, respectively. Consistent with the favorable log <i>D</i> at pH 7.4 of 2.3, the permeability in wild-type MDCK cells was in an acceptable range for CNS drugs (<i>P</i><sub>app</sub> = 20.4 × 10<sup>–6</sup> cm/s). Prior to PK studies in multiple species, liver microsomal stability and the fraction unbound in serum (<i>f</i><sub>u,s</sub>) were determined. Like the stability in HLM, compound <b>15</b> was found to be stable in mouse, dog, and monkey microsomes (69%, 87%, and 79% remaining after 30 min, respectively), and its <i>f</i><sub>u,s</sub> was moderate to high in rat, mouse, dog, monkey, and guinea pig (0.16, 0.30, 0.11, 0.22, and 0.42, respectively). Brain tissue binding in rat was found to be moderate (<i>f</i><sub>u,b</sub> = 0.066) as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Compound <b>15</b> was also evaluated for its ability to inhibit a panel of cytochrome P450s and exhibited IC<sub>50</sub> values of more than 20 μM over 1A2, 2C9, 2C19, 2D6 and 3A4. Additionally, <b>15</b> did not show time-dependent inhibition of CYP3A4 up to 20 μM. The hERG IC<sub>50</sub> value using a manual patch clamp method was determined to be 2.0 μM. The close analog 4-fluoromethyl <b>14</b> exhibited hERG IC<sub>50</sub> of 3.9 μM reflecting the difference in % inhibition at 5 μM. Compound <b>15</b> was tested against other aspartyl proteases, cathepsin D (CatD) and BACE2. Although <b>15</b> showed limited selectivity over BACE2 (IC<sub>50</sub> = 86.3 nM), no significant inhibition was observed in CatD (IC<sub>50</sub> > 100 μM). Solid state stability testing for <b>15</b> was conducted at 40 °C/89% relative humidity (RH), where a degradation product increased by 0.06%, indicating that <b>15</b> was almost stable. Because <b>15</b> has a potential to generate anilines as metabolites (a structural alert), the Ames test was conducted to estimate the genetic toxicity of this series. Five mutant strains of TA100, TA1535, TA1537, TA98, and WP2uvrA were used in the presence and absence of the rat S9 fraction. Negative results were observed for <b>15</b> at doses up to 5 mg/plate. Also, the corresponding aniline dihydrochloride was found to be negative in the Ames test.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Brain Penetration in Wild-Type and Mdr1a Knockout Mouse</h3><div class="NLM_p">From exploration of the head group, compound <b>15</b> provided lower efflux ratios in MDCK cells transfected with human MDR1 relative to the initial lead <b>6</b>. To investigate the potential impact of P-gp in vivo, we utilized <i>mdr1a</i> knockout (KO) mouse to determine <i>B</i>/<i>P</i> ratios in knockout versus wild-type (WT). For comparison, oxazine <b>14</b> with a lower P-gp efflux of 9.0 and dihydrooxazine <b>6</b> with a higher P-gp efflux of 36 were included in the tests. The compounds were administered orally at doses of 2 and 10 mg/kg (2 mg/kg for <b>6</b> and <b>15</b>, 10 mg/kg for <b>14</b>). Clearly, the P-gp efflux ratios were translated into the KO/WT ratios of the <i>B</i>/<i>P</i> values. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, the <i>B</i>/<i>P</i> ratios in WT mouse were comparable to those in rat in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, while increased <i>B</i>/<i>P</i> ratios were observed in P-gp KO mouse, indicating that these compounds were P-gp substrates in mouse. Despite the low lipophilicity of the initial lead <b>6</b> (log <i>D</i> = 0.024) and the low permeability (<i>P</i><sub>app</sub> = 0.32 × 10<sup>–6</sup> cm/s), the <i>B</i>/<i>P</i> ratio in the KO mouse significantly increased to 4.7 (from 0.15 in the WT counterpart), which highlighted the important role of P-gp in brain penetration. The <i>B</i>/<i>P</i> ratios in the KO mouse for <b>14</b> and <b>15</b> were 2.5 and 4.4 resulting in KO/WT ratios of 2.5 and 3.6, respectively, demonstrating the improvement in P-gp efflux for <b>14</b> and <b>15</b> in vivo relative to <b>6</b> (KO/WT = 32). According to the analysis at Pfizer for successful CNS drugs using P-gp KO mouse,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> KO/WT ratios of 2–3 appeared to be in an acceptable range. Thus, although both <b>14</b> and <b>15</b> were still found to be P-gp substrates in mouse, the magnitude of the potential clinical effects for <b>14</b> and <b>15</b> may be low.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Brain Penetrations of <b>6</b>, <b>14</b>, and <b>15</b> in Wild-Type (C57BL/6J) and <i>mdr1a</i> (−/−) Mouse</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center">po, 2 or 10 mg/kg, <i>n</i> = 3<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">P-gb ER<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">dose (mg)</th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b</sub> (ng/g)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p</sub> (ng/mL)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>B</i>/<i>P</i><a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">KO/WT<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">14.5</td><td class="colsep0 rowsep0" align="left">102</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KO</td><td class="colsep0 rowsep0" align="left">546</td><td class="colsep0 rowsep0" align="left">118</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">341</td><td class="colsep0 rowsep0" align="left">336</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KO</td><td class="colsep0 rowsep0" align="left">903</td><td class="colsep0 rowsep0" align="left">363</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">92.6</td><td class="colsep0 rowsep0" align="left">76.1</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KO</td><td class="colsep0 rowsep0" align="left">318</td><td class="colsep0 rowsep0" align="left">71.5</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Dosed as a suspension of test compounds in 0.5% methylcellulose (MC).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Efflux ratio measured in MDCK cells transfected with human MDR1 at absorption systems.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">KO = <i>mdr1a</i> (−/−) mouse; WT = wild-type (C57BL/6J) mouse (vehicle = 0.5% MC).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Brain concentration at 2 h time point.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Plasma concentration at 2 h time point.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Brain-to-plasma total concentration ratio (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>).</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">KO/WT = (<i>B</i>/<i>P</i> in KO)/(<i>B</i>/<i>P</i> in WT).</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Neuropharmacokinetic Studies of <b>15</b> in Multiple Species</h3><div class="NLM_p">Investigations of pharmacokinetic properties of <b>15</b> were conducted using Sprague-Dawley rats, beagle dogs, and cynomolgus monkeys. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, exposure and plasma levels were high in rats after oral administration of <b>15</b> at doses of 1, 3, and 10 mg/kg. At 1 mg/kg, the maximum concentration (<i>C</i><sub>max</sub>) and the area under the curve (AUC) were at similar levels to those in the cassette method (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> vs <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Also, the intravenous administration at 2 mg/kg provided comparable results to those from the cassette method of 0.5 mg/kg. The dose-proportionality of <b>15</b> was maintained between the given doses. Compound <b>15</b> showed high exposure, moderate clearance, and moderate to high volume of distribution. To assess neuropharmacokinetic profiles of <b>15</b>, compound levels in the brain and CSF were also measured at the po dose of 3 mg/kg (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Total <i>B</i>/<i>P</i> ratios (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>, 0.70–0.83) were similar to unbound brain-to-plasma ratios based on CSF levels (<i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub>, 0.51–0.78), while those based on unbound brain levels (<i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub>; <i>C</i><sub>b,u</sub> = <i>C</i><sub>b</sub> × <i>f</i><sub>u,b</sub>; 0.29–0.34) decreased 2-fold relative to the total <i>B</i>/<i>P</i> and <i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub> ratios. The higher <i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub> ratio could be rationalized by the observed P-gp effect in mouse, because P-gp works as an active transporter at the blood-CSF barrier.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of <b>15</b> at Multiple Doses in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center">rat, po, <i>n</i> = 3<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">dose</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">70.0 ± 9.0</td><td class="colsep0 rowsep0" align="left">358 ± 20</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">274 ± 22</td><td class="colsep0 rowsep0" align="left">2040 ± 570</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">965 ± 233</td><td class="colsep0 rowsep0" align="left">4990 ± 1000</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">rat, iv, <i>n</i> = 3<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">Vd<sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)<a class="ref internalNav" href="#t5fn9" aria-label="i">i</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">15.4 ± 2.1</td><td class="colsep0 rowsep0" align="left">2.93 ± 0.33</td><td class="colsep0 rowsep0" align="left">2.45 ± 0.53</td><td class="colsep0 rowsep0" align="left">2190 ± 300</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Dosed as a suspension of <b>15</b> in 0.5% MC.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Maximal plasma concentration.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Plasma area under the curve (po).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Dosed as a solution of <b>15</b> in DMA/PG = 1/1.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Total clearance.</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t5fn8"><sup><sup>h</sup></sup><p class="last">Half-life (iv).</p></div><div class="footnote" id="t5fn9"><sup><sup>i</sup></sup><p class="last">Plasma area under the curve (iv).</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. CNS Availability Data for <b>15</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">time after administration, po, 3 mg/kg, <i>n</i> = 3<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">3 h</th><th class="colsep0 rowsep0" align="center">5 h</th><th class="colsep0 rowsep0" align="center">7 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>p</sub> (ng/mL)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">70.0 ± 9.0</td><td class="colsep0 rowsep0" align="left">51.0 ± 5.8</td><td class="colsep0 rowsep0" align="left">19.5 ± 4.7</td><td class="colsep0 rowsep0" align="left">19.6 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b</sub> (ng/g)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">48.9 ± 1.6</td><td class="colsep0 rowsep0" align="left">42.2 ± 8.4</td><td class="colsep0 rowsep0" align="left">16.1 ± 5.8</td><td class="colsep0 rowsep0" align="left">15.5 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b,u</sub> (ng/g)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">3.2 (8.4 nM)</td><td class="colsep0 rowsep0" align="left">2.8 (7.2 nM)</td><td class="colsep0 rowsep0" align="left">1.1 (2.8 nM)</td><td class="colsep0 rowsep0" align="left">1.0 (2.7 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>CSF</sub> (ng/mL)<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">7.5 ± 1.2 (20 nM)</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.4 (13 nM)</td><td class="colsep0 rowsep0" align="left">2.4 ± 1.4 (6.3 nM)</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.4 (4.2 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b</sub>/C<sub><i>p</i></sub><a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">0.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t6fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t6fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="left">0.61</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Dosed as a suspension of <b>15</b> in 0.5% MC.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Plasma concentration.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Brain concentration.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Unbound brain concentration (<i>C</i><sub>b,u</sub> = <i>C</i><sub>b</sub> × <i>f</i><sub>u,b</sub>).</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Cerebrospinal fluid (CSF) concentration.</p></div><div class="footnote" id="t6fn6"><sup><sup>f</sup></sup><p class="last">Total brain-to-plasma ratio (<i>B</i>/<i>P</i> or <i>K</i><sub>p</sub>).</p></div><div class="footnote" id="t6fn7"><sup><sup>g</sup></sup><p class="last">Unbound brain-to-plasma ratio (<i>K</i><sub>p,uu</sub>). <i>C</i><sub>b,u</sub> = <i>C</i><sub>b</sub> × <i>f</i><sub>u,b</sub> (unbound brain fraction in rat). <i>C</i><sub>p,u</sub> = <i>C</i><sub>p</sub> × <i>f</i><sub>u,s</sub> (unbound serum fraction in rat).</p></div><div class="footnote" id="t6fn8"><sup><sup>h</sup></sup><p class="last">CSF-to-unbound plasma ratio (<i>K</i><sub>p,uu</sub> (CSF)).</p></div></div></div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> summarizes the pharmacokinetic data for beagle dog and cynomolgus monkey. In dog, <b>15</b> displayed low clearance, moderate to high Vd<sub>ss</sub>, a decent exposure level (AUC), and high bioavailability following an iv dose of 1 mg/kg and a po dose of 0.75 mg/kg (day 1). After repeated daily po doses, slight increases in <i>C</i><sub>max</sub> and AUC were seen on day 7. In contrast to dog, a higher clearance and decreased bioavailability were observed in monkey, most likely due to decreased microsomal stability and higher <i>f</i><sub>u,s</sub> as shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. To compare rat and dog CNS availability, compound levels in CSF were measured at 10 and 24 h after dosing on day 7, where comparable <i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub> ratios were obtained between rat and dog. On the basis of the good brain penetration observed, <b>15</b> was subjected to pharmacokinetic/pharmacodynamics (PK/PD) study.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Properties of <b>15</b> in Beagle Dog and Cynomolgus Monkey</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">iv, 1 mg/kg, <i>n</i> = 3<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="3" align="center">po, 075 mg/kg (dog), 1 mg/kg (monkey), <i>n</i> = 3<a class="ref internalNav" href="#t7fn7" aria-label="g">g</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">LM (%)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,s</sub> (%)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CL (mg min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Vd<sub>ss</sub>(L/kg)<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)<a class="ref internalNav" href="#t7fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#t7fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)<a class="ref internalNav" href="#t7fn10" aria-label="j">j</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog (day 1)</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">5.95 ± 1.4</td><td class="colsep0 rowsep0" align="left">2.66 ± 0.69</td><td class="colsep0 rowsep0" align="left">5.75 ± 0.28</td><td class="colsep0 rowsep0" align="left">2403 ± 644</td><td class="colsep0 rowsep0" align="left">173 ± 24.9</td><td class="colsep0 rowsep0" align="left">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog (day 7)<a class="ref internalNav" href="#t7fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">2722 ± 743</td><td class="colsep0 rowsep0" align="left">198 ± 31.8</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">20.8 ± 5.3</td><td class="colsep0 rowsep0" align="left">5.01 ± 1.09</td><td class="colsep0 rowsep0" align="left">5.48 ± 0.31</td><td class="colsep0 rowsep0" align="left">924 ± 173</td><td class="colsep0 rowsep0" align="left">92.9 ± 30.2</td><td class="colsep0 rowsep0" align="left">37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">% remaining in dog or monkey liver microsomes after 30 min incubation.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Fraction unbound in dog or monkey serum.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Dosed as a solution of <b>15</b> in DMA/PG/hydroxypropyl-β-cyclodextrin (HPBCD) = 1/3/1 for dog and in HPBCD for monkey. NT = not tested.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">Total clearance.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t7fn6"><sup><sup>f</sup></sup><p class="last">Half-life (iv).</p></div><div class="footnote" id="t7fn7"><sup><sup>g</sup></sup><p class="last">Dosed as a suspension of <b>15</b> in 0.5% MC.</p></div><div class="footnote" id="t7fn8"><sup><sup>h</sup></sup><p class="last">Plasma area under the curve (po).</p></div><div class="footnote" id="t7fn9"><sup><sup>i</sup></sup><p class="last">Maximal plasma concentration.</p></div><div class="footnote" id="t7fn10"><sup><sup>j</sup></sup><p class="last">Oral bioavailability. ND = not determined.</p></div><div class="footnote" id="t7fn11"><sup><sup>k</sup></sup><p class="last">After 7 days of once daily dosing, plasma samples were collected for up to 24 h.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> PK/PD Studies of <b>15</b> in Mouse and Dog</h3><div class="NLM_p">To assess BACE1 inhibition in vivo, we used Crlj:CD (ICR) mouse<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and beagle dog. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, <b>15</b> demonstrated robust and sustained reduction of total Aβ levels in the brain over 8 h following a po dose of 10 mg/kg. The maximum Aβ reduction of 69% was observed at 4 h, where the brain level reached 295 ng/mL (<i>C</i><sub>b,u</sub> = 51 nM), which was 14-fold higher than a cellular IC<sub>50</sub> value of 3.6 nM. Even at 8 h, <b>15</b> achieved 1.9-fold higher unbound brain level than the IC<sub>50</sub>, explaining the sustained Aβ reduction in mouse.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Total Aβ reduction in mouse after an oral dose of <b>15</b> at 10 mg/kg (<i>n</i> = 4). Compound <b>15</b> was dosed as a solution of 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dog models for assessing the potential of inhibiting Aβ production are useful intermediates between models for mice and humans, because pathological changes of Aβ production in dogs are similar to those in humans, and dogs also develop Aβ plaques thereby being considered as a natural model of age-dependent cognitive dysfunction.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> To determine the plasma level that can achieve Aβ reduction by 50% (EC<sub>50</sub>), a PK/PD study in dog was conducted at multiple doses of 0.31, 1.25, and 5 mg/kg.<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> The plasma samples were taken at 0.5, 1, 2, 4, 8, and 25 h after dosing, and the CSF was sampled in conscious dogs from the lateral ventricle before dosing and at 4, 8, and 25 h after dosing. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <b>15</b> demonstrated a dose-dependent and sustained decrease in CSF Aβ 40 and 42. Importantly, even at 1.25 mg/kg, a robust CSF Aβ reduction of more than 70% was achieved at 8 h. Finally, the EC<sub>50</sub> value in plasma was determined to be 62 ng/mL (unbound EC<sub>50</sub>, EC<sub>50,u</sub> = 18 nM); the EC<sub>50</sub> value in CSF was estimated to be 10 nM using the <i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub> ratios of 0.56 in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, which was 3-fold higher than the cellular IC<sub>50</sub> value of 3.6 nM. For comparison, a dog PK/PD study for <b>14</b> was also done, and the EC<sub>50</sub> value for Aβ42 was found to be 145 ng/mL (EC<sub>50,u</sub> = 45 nM, <i>f</i><sub>u,s</sub> in dog = 0.12), reflecting the difference in the cellular IC<sub>50</sub> values between <b>14</b> and <b>15</b> of 17 nM and 3.6 nM, respectively.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. CNS Availability Data for <b>15</b> in Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="8" align="center">po (day7), 0.75 mg/kg, <i>n</i> = 3<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">10 h, ng/mL</th><th class="rowsep1 colsep0" colspan="4" align="center">24 h, ng/mL</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p</sub><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub>/<i>C</i><sub>p,u</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">6.8 (18 nM)</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">27.7</td><td class="colsep0 rowsep0" align="left">3.05</td><td class="colsep0 rowsep0" align="left">1.7 (4.4 nM)</td><td class="colsep0 rowsep0" align="left">0.56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">After 7 days of once daily dosing (po, 0.5% MC), cisternal CSF samples were collected from anesthetized dogs at 10 and 24 h time points.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">Plasma concentration measured in the experiment in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Unbound plasma concentration (<i>C</i><sub>p,u</sub> = <i>C</i><sub>p</sub> × <i>f</i><sub>u,s</sub> (unbound plasma fraction in dog)).</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last">Cerebrospinal fluid (CSF) concentration.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">CSF-to-unbound plasma ratio (<i>K</i><sub>p,uu</sub> (CSF)).</p></div></div></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CSF Aβ1–40, and Aβ1–42 reduction in beagle dog after oral doses of <b>15</b> at 0.31, 1.25, and 5 mg/kg (<i>n</i> = 4). Compound <b>15</b> was dosed as a solution of 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cardiovascular Safety of <b>15</b> in Anesthetized Guinea Pig and Conscious Dog</h3><div class="NLM_p">To investigate the cardiovascular profile of <b>15</b>, we first utilized an anesthetized guinea-pig model. Increasing doses of <b>15</b> (3, 10, and 30 mg/kg) were administered intravenously over a period of 10 min at 30 min intervals to urethane-anesthetized guinea pigs. The average unbound plasma levels of <b>15</b>, measured at the end of the intravenous infusions of 3, 10, and 30 mg/kg, were 0.907, 4.31, and 13.4 μM, respectively. Compared to the vehicle, <b>15</b> significantly increased the duration of QTc interval (13.9%) and decreased the heart rate at 30 mg/kg. The unbound no-observed-adverse-effect level (NOAEL) for cardiovascular safety in guinea pig is 4.31 μM, and the safety margin over the dog EC<sub>50,u</sub> was calculated to be 239-fold wide safety margin.</div><div class="NLM_p last">The cardiovascular effects of <b>15</b> in conscious dogs were then studied. On the basis of the dog PK study in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> and the NOAEL in guinea pigs, <b>15</b> was orally administered at doses of 30 and 100 mg/kg. No significant effects on arterial blood pressure, heart rate, PR interval, and QTc interval were observed at 30 mg/kg, while statistically significant increases in heart rate and QTc interval (16.1%) were observed at 100 mg/kg. The unbound maximum concentrations (<i>C</i><sub>max,u</sub>) for 30 and 100 mg/kg were 1.40 and 3.21 μM, respectively; <b>15</b> had a NOAEL of 1.40 μM, which was close to the hERG IC<sub>50</sub> value of 2.0 μM, establishing the safety margin of 78-fold over dog EC<sub>50,u</sub>. Although the margin was lower than observed for guinea pigs, it was still in an acceptable range.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of oxazine <b>11</b> is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Condensation of acetophenone <b>30</b> with (<i>R</i>)-<i>tert</i>-butysulfinamide<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> using Ti(OEt)<sub>4</sub> afforded ketimine <b>31</b>. This was followed by reduction of the nitro group and trifluoroacetylation with trifluoroacetic anhydride (TFAA) to provide <b>32</b>. Addition of allyl Grignard reagent to the ketimine <b>32</b> afforded compound <b>33</b> as a single diastereomer, which was followed by ozonolysis to give aldehyde <b>34</b>. The <i>tert</i>-butylsulfinyl group in <b>34</b> was removed with HCl in MeOH to give acetal <b>35</b>, which was then reacted with triphosgene followed by diallylamine, yielding urea <b>36</b>. The oxazine ring was formed using Burgess reagent<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> in the presence of pyridinium <i>p</i>-toluenesulfonate (PPTS) to provide <b>37</b>. Deprotection of the trifluoroacetyl group in <b>37</b> and amide coupling with 5-cyanopicolinic acid followed by deprotection of the diallyl group in <b>39</b> in the presence of palladium catalyst afforded the oxazine <b>11</b>. The stereochemistry of <b>11</b> was confirmed by single crystal X-ray analysis of compound <b>18</b>, which was synthesized via the intermediate <b>33</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxazine <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-2-methylpropane-2-sulfinamide, Ti(OEt)<sub>4</sub>, THF, 65 °C, 65%; (b) (i) Fe, NH<sub>4</sub>Cl, toluene–H<sub>2</sub>O, 80 °C, (ii) TFAA, Et<sub>3</sub>N, THF, – 25 °C, 78%; (c) allylmagnesium bromide, THF, – 78 °C, 40%; (d) O<sub>3</sub>, DCM, – 78 °C, 88%; (e) 2 N HCl in MeOH, rt, 56%; (f) triphosgene, Et<sub>3</sub>N, diallylamine, H<sub>2</sub>O–EtOAc, 0 °C, 82%; (g) (i) aq H<sub>2</sub>SO<sub>4</sub>, acetone, (ii) Burgess reagent, PPTS, THF, reflux, 24%; (h) K<sub>2</sub>CO<sub>3</sub>, THF–MeOH–H<sub>2</sub>O, 40 °C, 87%; (i) EDC, HOBt, DMAP, 5-cyanopicolinic acid, DMF, rt, 92%; (j) 1,3-dimethylbarbituric acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, DCM, reflux, 58%.</p></p></figure><div class="NLM_p">The 6-fluoromethyl substituted oxazines <b>15</b> and <b>20</b>–<b>28</b> were synthesized via the route outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Sulfinyl ketimine <b>40</b>, prepared from the commercially available 2-fluoroacetophenone, was reacted with allyl Grignard reagent to provide compound <b>41</b> as a single diastereomer, which was followed by cleavage of the sulfinyl group to afford allyl amine <b>42</b>. Urea formation was done with 4-nitrophenyl chloroformate and bis(2,4-dimethoxybenzyl)amine to give urea <b>43</b>, which was then oxidized to the hydroxy ketone <b>44</b>. Use of 4-nitrophenyl chloroformate, instead of triphosgene, under the Schotten–Baumann reaction conditions avoided formation of a side product affording <b>43</b> with improved yield. Unlike <b>36</b>, cyclization of the ketone <b>43</b> was accomplished without PPTS using Burgess reagent, furnishing oxazine <b>45</b>. Replacement of the mesylate group with NaI to <b>46</b> followed by fluorination using AgF led to 6-fluoromethyl oxazine <b>47</b>. After cleavage of the bis-2,4-dimethoxybenzyl group using TFA, <b>48</b> was subjected to nitration reaction, which was followed by reduction of the nitro group and subsequent Boc protection resulting in aniline <b>51</b>. Finally, amide formation followed by deprotection delivered the 6-fluoromethyl substituted oxazines <b>15</b> and <b>20</b>–<b>28</b>. The absolute configuration was confirmed by the X-ray structure of <b>15</b> bound to BACE1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Oxazines <b>15</b> and <b>20</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allylmagnesium bromide, Et<sub>2</sub>O, – 60 to −20 °C, 72%; (b) 4 N HCl in EtOAc, MeOH, 0 °C, quant; (c) 4-nitrophenyl chloroformate, K<sub>2</sub>CO<sub>3</sub>, bis(2,4-dimethoxybenzyl)amine, EtOAc–H<sub>2</sub>O, 0 °C to rt, 82%; (d) KMnO<sub>4</sub>, AcOH, acetone–H<sub>2</sub>O, rt, 68%; (e) (i) Ms<sub>2</sub>O, DCM, 0 °C, (ii) Burgess reagent, THF, rt, 40%; (f) NaI, acetone, rt, 95%; (g) AgF, MeCN, rt, 98%; (h) anisole, TFA, 80 °C, quant; (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>–TFA, – 20 °C, 94%; (j) Boc<sub>2</sub>O, DMAP, THF, 0 °C, 90%; (k) Fe, NH<sub>4</sub>Cl, EtOH–THF–H<sub>2</sub>O, 60 °C, 85%; (l) (i) HATU, RCO<sub>2</sub>H, DIEA, DCM, rt, (ii) HCO<sub>2</sub>H, rt, 61–95%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Lead optimization efforts on the dihydrooxazine <b>6</b> led to the discovery of a series of oxazines exemplified by <b>15</b> with improved P-gp efflux resulting in robust Aβ reduction in the brain. We employed a p<i>K</i><sub>a</sub> lowering approach on the amidine moiety by incorporating a double bond in an attempt to mitigate the high P-gp efflux observed in <b>6</b>. This led to identification of oxazine <b>11</b> with improved P-gp efflux, which we believe is the first report of using a double bond to reduce the p<i>K</i><sub>a</sub> of basic amines for BACE1 inhibitors. Subsequent optimization of the head group followed by the tail culminated in <b>15</b> as the best in the series. The P-gp knockout mouse study suggested that the significant improvement in brain penetration observed in <b>15</b> relative to <b>6</b> resulted from the reduced P-gp efflux. The decent unbound <i>B</i>/<i>P</i> ratios as well as adequate target coverage were confirmed with the rat and dog neuroPK studies. Reflecting CNS availability, <b>15</b> displayed a significant Aβ reduction in mouse at 10 mg/kg and a low Aβ42 EC<sub>50</sub> value of 62 ng/mL in dog. While <b>15</b> still inhibited the hERG channel at 5 μM, wide safety margins over the dog EC<sub>50</sub> were demonstrated in the cardiovascular safety models. Finally, the well characterized <b>15</b> using neuropharmacokinetic models, a P-gp KO mouse model, and in vivo cardiovascular models should serve as a useful tool for finding BACE1 inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Chemistry</h3><div class="NLM_p last">All commercial reagents and solvents were used as received unless otherwise noted. Thin layer chromatography (TLC) analysis was performed using Merck silica gel 60 F<sub>254</sub> thin layer plates (250 μm in thickness). Flash column chromatography was carried out on an automated purification system using Yamazen or Fuji Silysia prepacked silica gel columns. <sup>1</sup>H NMR spectra were recorded on a Bruker Advance 400 MHz. Spectral data are reported as follows: chemical shift (as ppm referenced to tetramethylsilane), multiplicity (s = singlet, d = doublet, dd = double doublets, dt = double triplet, t = triplet, q = quartet, m = multiplet, br = broad peak), coupling constant, and integration value. Analytical LC/MS was performed on a Shimadzu Shim-pack XR-ODS (C<sub>18</sub>, 2.2 μm, 3.0 mm × 50 mm, a linear gradient from 10% to 100% B over 3 min and then 100% B for 1 min (A = H<sub>2</sub>O + 0.1% formic acid, B = MeCN + 0.1% formic acid), flow rate 1.6 mL/min) using a Shimadzu UFLC system equipped with a LCMS-2020 mass spectrometer, LC-20AD binary gradient module, SPD-M20A photodiode array detector (detection at 254 nm), and SIL-20AC sample manager. The purity of all compounds used in the bioassays was determined by this method to be >95%. High resolution mass spectra were recorded on a Thermo Fisher Scientific LTQ Orbitrap using electrospray positive ionization.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>39</b> (66.9 mg, 0.155 mmol) and 1,3-dimethylbarbituric acid (145 mg, 0.930 mmol) in DCM (1.0 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (17.9 mg, 0.016 mmol). The mixture was refluxed for 2 h. The mixture was diluted with EtOAc and saturated aq NaHCO<sub>3</sub> solution. The aqueous layer was separated and then extracted with EtOAc. The combined organic extracts were washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (amino silica gel; hexane/EtOAc, gradient 20–50% EtOAc) to give <b>11</b> (32 mg, 58% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.56 (s, 3H), 4.11 (br s, 2H), 5.56 (dd, <i>J</i> = 6.1, 2.5 Hz, 1H), 6.37 (d, <i>J</i> = 6.1 Hz, 1H), 7.06 (dd, <i>J</i> = 11.2, 8.6 Hz, 1H), 7.67 (dd, <i>J</i> = 4.1, 3.0 Hz, 1H), 7.91–7.95 (m, 1H), 8.20 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.43 (d, <i>J</i> = 8.1 Hz, 1H), 8.89 (d, <i>J</i> = 6.1, 2.0 Hz, 1H), 9.85 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 352 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>51</b> (10.3 g, 22.7 mmol), DIEA (7.92 mL, 45.3 mmol), and 5-cyanopicolinic acid monohydrate (4.52 g, 27.2 mmol) in DCM (100 mL) was added HATU (10.3 g, 27.2 mmol) at room temperature, and the reaction mixture was stirred for 3 h at the same temperature. The mixture was diluted with saturated aq NaHCO<sub>3</sub> solution and DCM. The aqueous layer was separated and extracted with DCM. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 30–50% EtOAc) to afford a yellow solid. The solid was dissolved with HCO<sub>2</sub>H (64 mL), and the mixture was stirred at room temperature for 2 h. The reaction mixture was diluted with EtOAc and then basified with 30% aq Na<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (amino silica gel; hexane/EtOAc, gradient 40–80% EtOAc) to afford <b>15</b> (7.03 g, 89% yield) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66 (s, 3H), 4.26 (s, 2H), 4.74 (d, <i>J</i> = 47.7 Hz, 2H), 5.74 (dd, <i>J</i> = 5.1, 2.5 Hz, 1H), 7.06 (dd, <i>J</i> = 11.2, 9.1 Hz, 1H), 7.69 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H), 7.89–7.93 (m, 1H), 8.20 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.42 (d, <i>J</i> = 8.1 Hz, 1H), 8.89 (d, <i>J</i> = 2.0 Hz, 1H), 9.84 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 31.66, 54.46, 80.40, 110.73, 112.40, 115.78, 116.74, 119.37, 119.90, 122.33, 133.14, 135.69, 141.25, 142.94, 148.21, 150.64, 152.25, 156.52, 159.99. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>16</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub>, 384.1267; found, 384.1261. [α]<sub class="stack">D</sub><sup class="stack">20</sup> +34.7 (<i>c</i> 0.51, MeCN).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyano-3-methylpicolinamide (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared in a manner similar to that for <b>15</b> in 77% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.70 (s, 3H), 2.85 (s, 3H), 4.77 (d, <i>J</i> = 47.7 Hz, 2H), 5.80 (dd, <i>J</i> = 4.8, 2.6 Hz, 1H), 7.07 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 7.71 (dd, <i>J</i> = 6.9, 2.7 Hz, 1H), 7.80–7.86 (m, 1H), 7.90–7.92 (m, 1H), 8.60–8.61 (m, 1H), 10.01 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 398 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-3-chloro-5-cyanopicolinamide (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared in a manner similar to that for <b>15</b> in 67% yield.<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.73 (d, <i>J</i> = 47.7 Hz, 2H), 5.73 (dd, <i>J</i> = 5.1, 2.5 Hz, 1H), 7.06 (dd, <i>J</i> = 11.4, 8.9 Hz, 1H), 7.59 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H), 7.91–7.95 (m, 1H), 8.16 (d, <i>J</i> = 2.0 Hz, 1H), 8.76 (d, <i>J</i> = 2.0 Hz, 1H), 9.67 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 418 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyano-3-methoxypicolinamide (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared in a manner similar to that for <b>15</b> in 83% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.80 (s, 3H), 4.03 (s, 3H), 4.79 (d, <i>J</i> = 47.2 Hz, 2H), 5.79 (dd, <i>J</i> = 4.3, 2.3 Hz, 1H), 7.07 (dd, <i>J</i> = 11.4, 8.9 Hz, 1H), 7.61 (d, <i>J</i> = 6.9, 2.7 Hz, 1H), 7.59–7.64 (m, 2H), 8.46–8.47 (m, 1H), 9.69 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 414 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared in a manner similar to that for <b>15</b> in 70% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.07 (s, 3H), 4.73 (d, <i>J</i> = 47.7 Hz, 2H), 5.73 (dd, <i>J</i> = 4.8, 2.3 Hz, 1H), 7.04 (dd, <i>J</i> = 11.4, 8.9 Hz, 1H), 7.65 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H), 7.86–7.89 (m, 1H), 8.14 (s, 1H), 9.01 (s, 1H), 9.49 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 390 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared in a manner similar to that for <b>15</b> in 76% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.67 (s, 3H), 4.74 (d, <i>J</i> = 47.6 Hz, 2H), 5.75 (dd, <i>J</i> = 4.9, 2.6 Hz, 1H), 6.79 (t, <i>J</i> = 54.4 Hz, 1H), 7.07 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 7.70 (dd, <i>J</i> = 6.9, 2.9 Hz, 1H), 7.86–7.92 (m, 1H), 8.91 (s, 1H), 9.51 (s, 1H), 9.62 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 410 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was prepared in a manner similar to that for <b>15</b> in 59% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.66 (s, 3H), 4.74 (d, <i>J</i> = 47.7 Hz, 2H), 5.74 (dd, <i>J</i> = 4.8, 2.5 Hz, 1H), 6.15 (d, <i>J</i> = 51.0 Hz, 2H), 7.05 (dd, <i>J</i> = 11.4, 8.8 Hz, 1H), 7.67 (dd, <i>J</i> = 6.9, 2.8 Hz, 1H), 7.85–7.91 (m, 1H), 8.26–8.27 (m, 1H), 9.06 (s, 1H), 9.48 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 408. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub>, 408.1278; found, 408.1276.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-3-Amino-<i>N</i>-(3-(2-amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared in a manner similar to that for <b>15</b> in 95% yield. In this amidation reaction, the corresponding carboxylic acid lithium salt was used, and the reaction was conducted in DMF without DIEA. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.73 (d, <i>J</i> = 47.7 Hz, 2H), 5.74 (dd, <i>J</i> = 4.6, 2.4 Hz, 1H), 6.02 (d, <i>J</i> = 51.4 Hz, 2H), 7.01 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 7.52 (s, 1H), 7.63–7.64 (m, 1H), 7.74–7.75 (m, 1H), 9.50 (s, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>, 423.1387; found, 423.1385.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-2-(difluoromethyl)oxazole-4-carboxamide (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared in a manner similar to that for <b>15</b> in 64% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.74 (d, <i>J</i> = 47.6 Hz, 2H), 5.73 (dd, <i>J</i> = 4.7, 2.5 Hz, 1H), 6.69 (t, <i>J</i> = 52.4 Hz, 1H), 7.04 (dd, <i>J</i> = 11.2, 8.8 Hz, 1H), 7.62 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H), 7.76–7.82 (m, 1H), 8.38 (s, 1H), 8.61 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 399 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-2-(fluoromethyl)oxazole-4-carboxamide (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared in a manner similar to that for <b>15</b> in 61% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.73 (s, 3H), 4.76 (d, <i>J</i> = 47.4 Hz, 2H), 5.42 (d, <i>J</i> = 47.0 Hz, 2H), 5.76 (dd, <i>J</i> = 4.4, 2.4 Hz, 1H), 7.04 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 7.64 (dd, <i>J</i> = 6.9, 2.7 Hz, 1H), 7.76–7.80 (m, 1H), 8.31–8.32 (m, 1H), 8.70 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 381 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>,<i>E</i>)-<i>N</i>-(1-(2-Fluoro-5-nitrophenyl)ethylidene)-2-methylpropane-2-sulfinamide (<b>31</b>)</h3><div class="NLM_p last">To a solution of <b>30</b> (50.0 g, 273 mmol) and (<i>R</i>)-2-methylpropane-2-sulfinamide (36.4 g, 300 mmol) in THF (350 mL) was added Ti(OEt)<sub>4</sub> (106 g, 464 mmol) at room temperature, and the reaction mixture was stirred at 65 °C for 7 h. The mixture was allowed to cool to room temperature. To a solution of citric acid (166 g) in water/toluene (600 mL/660 mL) was added the reaction mixture at 10 °C. The mixture was stirred for 2 h and filtered through Celite. The aqueous layer was separated and extracted with toluene. The combined organic layers were evaporated, the resulting residue was treated with IPE (210 mL), and the mixture was stirred at 0 °C for 2 h. The resulting solid was collected on a Kiriyama funnel and washed with cooled IPE (100 mL) to afford <b>31</b> (50.6 g, 65% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.34 (s, 9H), 2.81 (s, 3H), 7.29 (t, <i>J</i> = 9.6 Hz, 1H), 8.30–8.34 (m, 1H), 8.55–8.57 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 287 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>R</i>,<i>E</i>)-<i>N</i>-(3-(1-((<i>tert</i>-Butylsulfinyl)imino)ethyl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>32</b>)</h3><div class="NLM_p last">A suspension of <b>31</b> (48.0 g, 168 mmol), Fe (32.8 g, 587 mmol), and NH<sub>4</sub>Cl (40.4 g, 754 mmol) in toluene/H<sub>2</sub>O (480 mL/192 mL) was stirred at 80 °C for 6 h. The mixture was cooled to room temperature and diluted with EtOAc (150 mL) and water (200 mL). The insoluble materials were filtered off, and the aqueous layer was separated and extracted with EtOAc. The combined organic layers were evaporated. The residue was dissolved in THF (156 mL) and Et<sub>3</sub>N (58.1 mL, 419 mmol), and the mixture was cooled to −40 °C. To this mixture was added dropwise TFAA (29.6 mL, 210 mmol) in THF (10 mL) at this temperature over 10 min, and the mixture was stirred at −25 °C for 30 min. The reaction was quenched with saturated aq NaHCO<sub>3</sub> solution (50 mL) at −25 °C, and the mixture was allowed to warm to room temperature and diluted with EtOAc (150 mL) and water (200 mL). The aqueous layer was separated and extracted with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was treated with IPE, and the mixture was stirred at room temperature. The resulting solid was collected on a Kiriyama funnel to afford <b>32</b> (46.0 g, 78% yield) as an orange solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.24 (s, 9H), 2.70 (s, 3H), 7.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.84–7.88 (m, 1H), 8.03–8.06 (m, 1H), 11.44 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 353 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(3-((<i>S</i>)-2-(((<i>R</i>)-<i>tert</i>-Butylsulfinyl)amino)pent-4-en-2-yl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>33</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (10 g, 28.4 mmol) in THF (100 mL) was added allyl magnesium bromide (1 M in THF, 100 mL) at −78 °C for 1 h. The reaction was quenched with saturated aq NH<sub>4</sub>Cl solution. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 0–30% EtOAc) to give <b>33</b> (4.5 g, 40% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21 (s, 9H), 1.68 (s, 3H), 2.79 (dd, <i>J</i> = 13.4, 7.3 Hz, 1H), 2.92 (dd, <i>J</i> = 13.4, 6.8 Hz, 1H), 4.16 (s, 1H), 5.10 (d, <i>J</i> = 9.6 Hz, 1H), 5.13 (d, <i>J</i> = 17.2 Hz, 1H), 5.51–5.65 (m, 1H), 6.95 (dd, <i>J</i> = 10.6, 10.1 Hz, 1H), 7.49–7.54 (m, 1H), 7.61–7.64 (m, 1H), 9.96 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 395 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(3-((<i>S</i>)-2-(((<i>R</i>)-<i>tert</i>-Butylsulfinyl)amino)-4-oxobutan-2-yl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>34</b>)</h3><div class="NLM_p last">A solution of compound <b>33</b> (4.5 g, 11.4 mmol) in DCM (90 mL) was cooled to −78 °C, and ozone gas was bubbled into the solution. When the color of the reaction solution changed to blue, the bubbling was stopped. Et<sub>3</sub>N (4.7 mL) was added to the solution, which was then stirred for an addtional 1 h at −78 °C. The mixture was warmed to room temperature and diluted with EtOAc and water. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to give <b>34</b> (4.0 g, 88% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.11 (s, 9H), 1.79 (s, 3H), 3.18 (s, 2H), 5.49 (s, 1H), 7.20 (dd, <i>J</i> = 12.2, 8.8 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.8, 4.0, 2.7 Hz, 1H), 7.84 (dd, <i>J</i> = 7.2, 2.7 Hz, 1H), 9.56 (s, 1H), 11.3 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 397 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4,4-dimethoxybutan-2-yl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>35</b>)</h3><div class="NLM_p last">To a solution of <b>34</b> (24.7 g, 62.3 mmol) in MeOH (250 mL) was added a solution of HCl (2 N in MeOH, 156 mL, 312 mmol). The mixture was stirred at room temperature for 22 h. The reaction mixture was evaporated, and then the residue was diluted with EtOAc. The mixture was poured into saturated aq NaHCO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 10–50% EtOAc) to give <b>35</b> (11.7 g, 56% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.79 (s, 3H), 2.04 (dd, <i>J</i> = 14.4, 7.2 Hz, 1H), 2.34–2.41 (m, 1H), 3.20 (s, 3H), 3.21 (s, 3H), 4.08–4.16 (m, 1H), 7.06 (dd, <i>J</i> = 11.4, 8.7 Hz, 1H), 7.59–7.64 (m, 1H), 7.69 (dd, <i>J</i> = 7.2, 3.0 Hz, 1H), 8.04 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 443 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-<i>N</i>-(3-(2-(3,3-Diallylureido)-4,4-dimethoxybutan-2-yl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>36</b>)</h3><div class="NLM_p last">To a solution of <b>35</b> (6.62 g, 19.6 mmol) and K<sub>2</sub>CO<sub>3</sub> (13.5 g, 98.0 mmol) in EtOAc (40 mL) and H<sub>2</sub>O (26 mL) was added a solution of triphosgene (5.81 g, 19.6 mmol) in EtOAc (25 mL) at 0 °C. The mixture was stirred at 0 °C for 1 h, and then a solution of diallylamine (5.70 g, 58.7 mmol) in EtOAc (13 mL) was added. The resulting mixture was stirred at 0 °C for 2 h and diluted with water. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 10–50% EtOAc) to give <b>36</b> (7.39 g, 82% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.92–1.96 (m, 1H), 2.34 (dd, <i>J</i> = 14.7, 5.4 Hz, 1H), 3.33 (s, 3H), 3.34 (s, 3H), 3.86 (dd, <i>J</i> = 16.8, 4.8 Hz, 2H), 3.97 (dd, <i>J</i> = 16.8, 4.8 Hz, 2H), 4.34 (t, <i>J</i> = 5.4 Hz, 1H), 5.26 (m, 4H), 5.80–5.90 (m, 2H), 6.51 (s, 1H), 6.90 (dd, <i>J</i> = 11.7, 8.7 Hz, 1H), 7.38–7.42 (m, 1H), 6.90 (dd, <i>J</i> = 7.5, 2.7 Hz, 1H), 9.14 (s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 462 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-<i>N</i>-(3-(2-(Diallylamino)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)-2,2,2-trifluoroacetamide (<b>37</b>)</h3><div class="NLM_p last">To a solution of <b>36</b> (7.39 g, 16.0 mmol) in acetone (100 mL) was added a solution of H<sub>2</sub>SO<sub>4</sub> (1 N in water; 48 mL). The mixture was stirred at room temperature for 2 h. The mixture was diluted with EtOAc and water. The aqueous layer was separated and then extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to give a residue (6.36 g) as a yellow oil. The residue was dissolved in THF (50 mL). Burgess regent (7.30 g, 30.6 mmol) and pyridinium <i>p</i>-toluenesulfonate (7.70 g, 30.6 mmol) were added to the solution, and the reaction mixture was refluxed for 7 h. After cooling to room temperature, the mixture was diluted with EtOAc and saturated aq NaHCO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 0–20% EtOAc) to give <b>37</b> (1.45 g, 24%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.60 (s, 3H), 3.85 (dd, <i>J</i> = 16.2, 5.7 Hz, 2H), 4.12–4.19 (m, 2H), 5.20–5.27 (m, 4H), 5.57 (dd, <i>J</i> = 6.0, 3.0 Hz, 1H), 5.83–5.95 (m, 2H), 6.38 (d, <i>J</i> = 6.0 Hz, 1H), 6.97–7.04 (m, 1H), 7.62–7.66 (m, 2H), 7.76 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 398 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>S</i>)-<i>N</i>,<i>N</i>-Diallyl-4-(5-amino-2-fluorophenyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine (<b>38</b>)</h3><div class="NLM_p last">To a solution of <b>37</b> (624 mg, 1.57 mmol) in THF (2.0 mL), MeOH (2.5 mL), and H<sub>2</sub>O (2.5 mL) was added K<sub>2</sub>CO<sub>3</sub> (651 mg, 4.71 mmol). The mixture was stirred at 60 °C for 7 h. After being cooled to room temperature, the mixture was diluted with EtOAc and water. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to give <b>38</b> (412 mg, 87% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.55 (s, 3H), 3.49 (br s, 2H), 3.86 (dd, <i>J</i> = 15.7, 5.6 Hz, 2H), 4.05 (dd, <i>J</i> = 15.7, 5.6 Hz, 2H), 5.13–5.21 (m, 4H), 5.55 (dd, <i>J</i> = 6.1, 3.0 Hz, 1H), 5.81–5.92 (m, 2H), 6.34 (d, <i>J</i> = 6.1 Hz, 1H), 6.47–6.52 (m, 1H), 6.77 (dd, <i>J</i> = 11.7, 8.6 Hz, 1H), 7.03–7.06 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 302 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>)-5-Cyano-<i>N</i>-(3-(2-(diallylamino)-4-methyl-4<i>H</i>-1,3-oxazin-4-yl)-4-fluorophenyl)picolinamide (<b>39</b>)</h3><div class="NLM_p last">To a solution of <b>38</b> (50.9 mg, 0.169 mmol), 5-cyanopocolinic acid monohydrate (33.7 mg, 0.203 mmol), 1-hydroxybenzotriazole hydrate (31.0 mg, 0.203 mmol), and DMAP (2.06 mg, 0.017 mmol) in DMF (1 mL) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (38.9 mg, 0.203 mmol). The mixture was stirred at room temperature for 2 h. The mixture was diluted with EtOAc and saturated aq NaHCO<sub>3</sub> solution. The aqueous layer was separated and then extracted with EtOAc. The combined organic extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 0–30% EtOAc) to give <b>39</b> (66.9 mg, 92% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.60 (s, 3H), 3.85 (dd, <i>J</i> = 16.2, 5.6 Hz, 2H), 4.15 (dd, <i>J</i> = 16.2, 5.6 Hz, 2H), 5.20–5.26 (m, 4H), 5.58 (dd, <i>J</i> = 6.1, 3.0 Hz, 1H), 5.88–5.99 (m, 2H), 6.38 (d, <i>J</i> = 6.1 Hz, 1H), 7.03 (dd, <i>J</i> = 11.2, 8.6 Hz, 1H), 7.74–7.79 (m, 1H), 7.92–7.96 (m, 1H), 8.20 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.43 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 8.90 (d, <i>J</i> = 1.0 Hz, 1H), 9.79 (br s, 1H). MS-ESI (<i>m</i>/<i>z</i>): 432 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>,<i>E</i>)-<i>N</i>-(1-(2-Fluorophenyl)ethylidene)-2-methylpropane-2-sulfinamide (<b>40</b>)</h3><div class="NLM_p last">To a suspension of 2-fluoroacetophenone (58.0 g, 420 mmol) and (<i>R</i>)-2-methylpropane-2-sulfinamide (66.2 g, 546 mmol) in toluene (290 mL) was added Ti(OEt)<sub>4</sub> (176 mL, 840 mmol) at room temperature, and the reaction mixture was stirred at 80 °C for 7 h. The reaction mixture was allowed to cool to room temperature and diluted with MeCN (1 L). To this mixture was added dropwise H<sub>2</sub>O (53 mL) at this temperature, and the mixture was stirred for 30 min. The resulting solid was filtered off, and the filtrate was evaporated to afford <b>40</b> (77.5 g, 77% yield) as an orange oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.32 (s, 9H), 2.77 (s, 3H), 7.06–7.13 (m, 1H), 7.15–7.20 (m, 1H), 7.39–7.45 (m, 1H), 7.65–7.70 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 242 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-<i>N</i>-((<i>S</i>)-2-(2-Fluorophenyl)pent-4-en-2-yl)-2-methylpropane-2-sulfinamide (<b>41</b>)</h3><div class="NLM_p last">To a solution of allylmagnesium bromide (1 M in Et<sub>2</sub>O; 721 mL, 721 mmol) was added <b>40</b> (58.0 g, 240 mmol) in Et<sub>2</sub>O (58 mL) dropwise over 10 min at −60 °C. The mixture was allowed to warm to −20 °C and then stirred for 50 min. The misture was again cooled to −50 °C, and a solutin of NH<sub>4</sub>Cl (65 0.0 g) in water (230 mL) was added dropwise to the mixture over 20 min. The aqueous layer was separated and then extracted with Et<sub>2</sub>O. The combined organic extracts were evaporated. The residue was treated with H<sub>2</sub>O (8.7 mL) and then hexane (464 mL) at 0 °C, and the resulting suspension was stirred at 0 °C for 1 h. The resulting solid was collected on a glass filter and washed with hexane to afford <b>41</b> (55.3 g, 72% yield) as a white solid. Compound <b>41</b> was obtained as a dihydrate form. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.81 (s, 3H), 2.82 (dd, <i>J</i> = 14.4, 7.5 Hz, 1H), 2.91 (dd, <i>J</i> = 14.4, 7.5 Hz, 1H), 3.99 (s, 1H), 5.07–5.11 (m, 1H), 5.12–5.19 (m, 1H), 5.46–5.56 (m, 1H), 7.00–7.07 (m, 1H), 7.09–7.14 (m, 1H), 7.26–7.31 (m, 1H), 7.35–7.41 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 284 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>S</i>)-2-(2-Fluorophenyl)pent-4-en-2-amine (<b>42</b>)</h3><div class="NLM_p last">To a solution of <b>41</b> (47.8 g, 0.151 mmol) in MeOH (143 mL) was added HCl (4 N in EtOAc; 59.4 mL, 238 mmol) at 0 °C, and the reaction mixture was stirred at room temperature for 2 h. The mixture was poured into ice–water. It was then washed with water and basified with NaOH solution (2 N in water, 135 mL). The aqueous layer was separated and extracted with Et<sub>2</sub>O. The combined organic extracts were evaporated to afford <b>42</b> (30.0 g, 106% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.52 (s, 3H), 2.48 (dd, <i>J</i> = 13.5, 7.8 Hz, 1H), 2.74 (dd, <i>J</i> = 13.5, 7.8 Hz, 1H), 4.99–5.09 (m, 2H), 5.47–5.61 (m, 1H), 6.98–7.05 (m, 1H), 7.06–7.12 (m, 1H), 7.17–7.22 (m, 1H), 7.39–7.45 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 180 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>)-1,1-Bis(2,4-dimethoxybenzyl)-3-(2-(2-fluorophenyl)pent-4-en-2-yl)urea (<b>43</b>)</h3><div class="NLM_p last">To a mixture of <b>42</b> (28.1 g, 148 mmol) and K<sub>2</sub>CO<sub>3</sub> (2 M in H<sub>2</sub>O; 82 mL, 164 mmol) in EtOAc (420 mL) and H<sub>2</sub>O (82 mL) was added 4-nitrophenyl chloroformate (31.4 g, 156 mmol) at 0 °C, and the suspension was stirred at the same temperature for 15 min. Bis(2,4-dimethoxybenzyl)amine (49.5 g, 156 mmol) was added portionwise at 0 °C, and the mixture was warmed to room temperature and then stirred for 4 h. The reaction mixture was diluted with water and EtOAc. The aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with aq K<sub>2</sub>CO<sub>3</sub> solution and water, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was crystallized from EtOAc, and the resulting solid was collected on a glass filter to afford <b>43</b> (63.2 g, 82% yield) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.76 (s, 3H), 2.52 (dd, <i>J</i> = 13.2, 7.6 Hz, 1H), 2.89 (dd, <i>J</i> = 13.2, 7.6 Hz, 1H), 3.76 (s, 6H), 3.81 (s, 6H), 4.37–4.46 (m, 4H), 4.88–4.90 (m, 1H), 4.90–4.95 (m, 1H), 5.35 (s, 1H), 5.42–5.53 (m, 1H), 6.43–6.47 (m, 4H), 6.97 (ddd, <i>J</i> = 12.8, 8.4, 1.2 Hz, 1H), 7.05 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.14–7.20 (m, 3H), 7.27 (td, <i>J</i> = 8.4, 1.6 Hz, 1H). MS-ESI (<i>m</i>/<i>z</i>): 523 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>)-1,1-Bis(2,4-dimethoxybenzyl)-3-(2-(2-fluorophenyl)-5-hydroxy-4-oxopentan-2-yl)urea (<b>44</b>)</h3><div class="NLM_p last">To a mixture of <b>43</b> (2.97 g, 5.68 mmol) in acetone (30 mL) and AcOH (2 M in H<sub>2</sub>O; 9.0 mL) was added dropwise a solution of KMnO<sub>4</sub> (1.62 g, 10.2 mmol) and AcOH (1 M in H<sub>2</sub>O; 15 mL) over 15 min on a water bath, and the reaction mixture was stirred at room temperature for 30 min. The reaction was quenched with 10% aq NaHSO<sub>3</sub> solution (10 mL) and then evaporated acetone. The resulting mixture was extracted with EtOAc, and the combined organic layers were washed with 10% aq Na<sub>2</sub>CO<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 50–80% EtOAc) to give <b>44</b> (2.13 g, 68% yield) as a while amorphous. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.77 (s, 3H), 3.07–3.11 (m, 1H), 3.76–3.81 (m, 1H), 3.77 (s, 6H), 3.81 (s, 6H), 3.90–3.93 (m, 1H), 4.07–4.09 (m, 1H), 4.36–4.48 (m, 4H), 5.87 (s, 1H), 6.43–6.49 (m, 4H), 6.97–7.06 (m, 2H), 7.13–7.21(m, 4H). MS-ESI (<i>m</i>/<i>z</i>): 555 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>S</i>)-(2-(Bis(2,4-dimethoxybenzyl)amino)-4-(2-fluorophenyl)-4-methyl-4<i>H</i>-1,3-oxazin-6-yl)methyl Methanesulfonate (<b>45</b>)</h3><div class="NLM_p last">To a solution of <b>44</b> (2.13 g, 3.84 mmol) and Et<sub>3</sub>N (799 μL, 5.76 mmol) in DCM (20 mL) was added methanesulfonic anhydride (736 mg, 4.22 mmol) at 0 °C, and the mixture was stirred at the same temperature for 30 min. The reaction mixture was diluted with saturated aq NaHCO<sub>3</sub> solution. The aqueous layer was separated and extracted with DCM. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was diluted with THF (25 mL). To the mixture was added Burgess reagent (1.83 g, 7.68 mmol), and the reaction mixture was stirred at room temperature for 2 h. The mixture was diluted with water, and the aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brain, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 30–50% EtOAc) to give <b>45</b> (944 mg, 40% yield) as a while amorphous. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.61 (s, 3H), 2.70 (s, 3H), 3.75 (s, 6H), 3.80 (s, 6H), 4.46 (d, <i>J</i> = 16.0 Hz, 2H), 4.55 (s, 2H), 4.66 (d, <i>J</i> = 16.0 Hz, 2H), 5.82 (d, <i>J</i> = 3.2 Hz, 1H), 6.43–6.46 (m, 4H), 6.93–7.00 (m, 2H), 7.13–7.18 (m, 3H), 7.46–7.51 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 615 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-<i>N</i>,<i>N</i>-Bis(2,4-dimethoxybenzyl)-4-(2-fluorophenyl)-6-(iodomethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine (<b>46</b>)</h3><div class="NLM_p last">To a solution of <b>45</b> (20.5 g, 33.4 mmol) in acetone (200 mL) was added NaI (10.0 g, 66.7 mmol) at room temperature. After stirring at the same temperature for 1 h, the mixture was filtered through Celite, and the filtrate was evaporated. The residue was diluted with EtOAc and water, and the aqueous layer was separated and then extracted with EtOAc. The combined organic layers were washed with 10% aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 20–40% EtOAc) to give <b>46</b> (20.5 g, 95% yield) as a pale yellow amorphous. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.55 (s, 3H), 3.72–3.73 (m, 2H), 3.75 (s, 6H), 3.81 (s, 6H), 4.48 (d, <i>J</i> = 16.0 Hz, 2H), 4.67 (d, <i>J</i> = 15.6 Hz, 2H), 5.72 (d, <i>J</i> = 3.2 Hz, 1H), 6.43–6.47 (m, 4H), 6.93–6.99 (m, 2H), 7.12–7.18 (m, 1H), 7.20 (d, <i>J</i> = 8.0 Hz, 2H), 7.51 (td, <i>J</i> = 8.4, 2.0 Hz, 1H). MS-ESI (<i>m</i>/<i>z</i>): 647 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-<i>N</i>,<i>N</i>-Bis(2,4-dimethoxybenzyl)-6-(fluoromethyl)-4-(2-fluorophenyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine (<b>47</b>)</h3><div class="NLM_p last">To a solution of <b>46</b> (20.5 g, 31.7 mmol) in MeCN (120 mL) was added AgF (10.1 g, 79.6 mmol) at room temperature. After being stirred at the same temperature for 16 h, the mixture was filtered through Celite, and the filtrate was evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 10–30% EtOAc) to give <b>47</b> (16.8 g, 98% yield) as a colorless amorphous. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.60 (s, 3H), 3.76 (s, 6H), 3.81 (s, 6H), 4.46 (d, <i>J</i> = 15.6 Hz, 2H), 4.65 (d, <i>J</i> = 16.0 Hz, 2H), 4.67 (d, <i>J</i> = 47.6 Hz, 2H), 5.76–5.78 (m, 1H), 6.44–6.46 (m, 4H), 6.93–6.99 (m, 2H), 7.12–7.19 (m, 3H), 7.48–7.52 (m, 1H). MS-ESI (<i>m</i>/<i>z</i>): 539 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-6-(Fluoromethyl)-4-(2-fluorophenyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine (<b>48</b>)</h3><div class="NLM_p last">A mixture of <b>47</b> (16.8 g, 31.1 mmol) and anisole (23.8 mL, 218 mmol) in TFA (84 mL) was stirred at 80 °C for 17 h. The reaction mixture was warmed to room temperature and evaporated. The residue was diluted with EtOAc and 10% aq Na<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (silica gel; hexane/EtOAc, gradient 50–80% EtOAc) to give <b>48</b> (7.64 g, 103% yield) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.20 (br s, 2H), 4.72 (d, <i>J</i> = 48.0 Hz, 2H), 5.70 (dd, <i>J</i> = 4.8, 2.4 Hz, 2H), 7.01 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.12 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.19–7.26 (m, 1H), 7.54 (td, <i>J</i> = 8.4, 2.0 Hz, 1H). MS-ESI (<i>m</i>/<i>z</i>): 239 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-4-(2-Fluoro-5-nitrophenyl)-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine (<b>49</b>)</h3><div class="NLM_p last">Compound <b>48</b> (7.41 g, 31.1 mmol) was dissolved in TFA (60 mL). The reaction mixture was cooled to −20 °C, and H<sub>2</sub>SO<sub>4</sub> (15 mL) was added. To the mixture was added dropwise HNO<sub>3</sub> (1.42 g/mL; 2.09 mL, 46.7 mmol) at −20 °C over 10 min. The reaction mixture was poured into ice–water and basified with 20% aq Na<sub>2</sub>CO<sub>3</sub> solution. The mixture was extracted with EtOAc, and the combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography (amino silica gel; hexane/EtOAc, gradient 30–50% EtOAc) to give <b>49</b> (8.41 g, 94% yield) as a pale yellow amorphous. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3H), 4.30 (br s, 2H), 4.74 (d, <i>J</i> = 47.2 Hz, 2H), 5.69 (dd, <i>J</i> = 4.4, 2.8 Hz, 2H), 7.16 (dd, <i>J</i> = 10.4, 8.8 Hz, 1H), 8.12–8.16 (m, 1H), 8.53 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H). MS-ESI (<i>m</i>/<i>z</i>): 284 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>tert</i>-Butyl <i>N</i>-[(<i>tert</i>-Butoxy)carbonyl]-<i>N</i>-[(4<i>S</i>)-4-(2-fluoro-5-nitrophenyl)-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-yl]carbamate (<b>50</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (8.41 g, 29.7 mmol) and DMAP (363 mg, 2.97 mmol) in THF (80 mL) was added Boc<sub>2</sub>O (14.5 mL, 62.4 mmol) at 0 °C, and the reaction mixture was warmed to room temperature and stirred for 2 h. The mixture was diluted with 15% aq citric acid solution and EtOAc. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water, saturated aq NaHCO<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was crystallized from Et<sub>2</sub>O to afford <b>50</b> (12.9 g, 90% yield) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.76 (dd, <i>J</i> = 47.2, 3.6 Hz, 2H), 5.63 (dd, <i>J</i> = 4.0, 2.8 Hz, 1H), 7.22 (dd, <i>J</i> = 10.4, 9.2 Hz, 1H), 8.17–8.21 (m, 1H), 8.52 (dd, <i>J</i> = 6.8, 2.8 Hz, 1H). MS-ESI (<i>m</i>/<i>z</i>): 484 [M + H]<sup>+</sup>..</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>tert</i>-Butyl <i>N</i>-[(4<i>S</i>)-4-(5-Amino-2-fluorophenyl)-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-yl]-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>51</b>)</h3><div class="NLM_p last">A suspension of <b>50</b> (12.9 g, 26.7 mmol), Fe (11.9 g, 213 mmol), and NH<sub>4</sub>Cl (17.1 g, 320 mmol) in EtOH/THF/H<sub>2</sub>O (100 mL/50 mL/50 mL) was stirred at 60 °C for 2 h. The reaction mixture was warmed to room temperature and filtered through Celite. The Celite was washed with EtOAc and water. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was crystallized from EtOAc/hexane to afford <b>51</b> (10.3 g, 85% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.51 (s, 18H), 1.69 (s, 3H), 3.54 (s, 2H), 4.74 (dd, <i>J</i> = 47.2, 2.0 Hz, 2H), 5.66 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 6.49–6.53 (m, 1H), 6.80–6.87 (m, 2H). MS-ESI (<i>m</i>/<i>z</i>): 454 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00002" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00002" class="ext-link">10.1021/acs.jmedchem.8b00002</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figure S1, experimental procedures, and characterization data for compounds <b>12</b>–<b>14</b>, <b>16</b>–<b>18</b> and the carboxylic acids for <b>25</b> and <b>26</b>, crystallographic information, methods for biological, DMPK, physicochemical, and toxicological assays (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILE strings, BACE1 IC<sub>50</sub>, cellular Aβ IC<sub>50</sub>, P-gp ER, hERG % inhibition at 5 μM, log <i>D</i>, p<i>K</i><sub>a</sub>, % remaining in HLM, and % remaining in RLM (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf">jm8b00002_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_002.csv">jm8b00002_si_002.csv (1.96 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray structure of <b>15</b> bound to human BACE1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY">5YGY</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00002" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken-ichi Kusakabe</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8de6e8e3a0e4eee5e4a3e6f8feece6ecefe8cdfee5e4e2e3e2eae4a3eee2a3e7fd"><span class="__cf_email__" data-cfemail="96fdf3f8bbfff5feffb8fde3e5f7fdf7f4f3d6e5fefff9f8f9f1ffb8f5f9b8fce6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kouki Fuchino</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasunori Mitsuoka</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moriyasu Masui</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noriyuki Kurose</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuhei Yoshida</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuo Komano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takahiko Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masayoshi Ogawa</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chie Unemura</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Motoko Hosono</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hisanori Ito</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaku Sakaguchi</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shigeru Ando</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuichi Ohnishi</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuto Kido</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tamio Fukushima</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hirofumi Miyajima</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuichi Hiroyama</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiyotaka Koyabu</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Dhuyvetter</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences and , Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Borghys</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences and , Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry and , Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshinori Yamano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuyoshi Iso</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.F., Y.M., and M.M. contributed equally to the rational design of the oxazine BACE1 inhibitors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d176e6191-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Tsuyoshi Hasegawa, Naohiro Onodera, Yoshiharu Hiramatsu, Satoshi Kasuya, and Azusa Nozu for their support with the syntheses, Tomoko Sasaki, Akihiro Matsuda, Hiroko Ogawa, Yukiko Fujioka, Yukari Tanaka, and Mikiko Kitade for the DMPK studies, Ayane Sakaguchi for the safety studies, Yuki Ishikawa for the HRMS analysis, and Yukiko Kan for the NMR analysis. We gratefully thank members of Janssen–Shionogi research collaboration for the support of this program. We are grateful to Judy Noguchi for proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amiloid β</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme</p></td></tr><tr><td class="NLM_term"><i>B</i>/<i>P</i></td><td class="NLM_def"><p class="first last">brain-to-plasma</p></td></tr><tr><td class="NLM_term">CE</td><td class="NLM_def"><p class="first last">capillary electrophoresis</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyl-4-aminopyridine</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HPBCD</td><td class="NLM_def"><p class="first last">2-hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1,2,3-benzotriazol-1-ol monohydrate</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IPE</td><td class="NLM_def"><p class="first last">isopropyl ether</p></td></tr><tr><td class="NLM_term">LLC-PK</td><td class="NLM_def"><p class="first last">pig-kidney derived epithelial</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Mardin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no observable adverse effect level</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PPTS</td><td class="NLM_def"><p class="first last">pyridinium <i>p</i>-toluenesulfonate</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Wimo, A.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Ali, G.-C.</span>; <span class="NLM_string-name">Wu, Y.-T.</span>; <span class="NLM_string-name">Prina, M.</span></span> World Alzheimer Report 2015. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a> (accessed June 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prince%2C+M.%3B+Wimo%2C+A.%3B+Guerchet%2C+M.%3B+Ali%2C+G.-C.%3B+Wu%2C+Y.-T.%3B+Prina%2C+M.+World+Alzheimer+Report+2015.+https%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf+%28accessed+June+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lg15gkYTvagAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lhKrllYqInmfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lhKrllYqInmfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lhKrllYqInmfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson-Croak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knops, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomensaari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1038/990114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2F990114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain&doi=10.1038%2F990114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540%26doi%3D10.1038%2F990114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloger, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingwall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-Secretase</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1006/mcne.1999.0811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-Secretase&doi=10.1006%2Fmcne.1999.0811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lgVIzseDvNLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-Secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427%26doi%3D10.1006%2Fmcne.1999.0811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2F990107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1456</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.4.1456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1073%2Fpnas.97.4.1456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein&doi=10.1073%2Fpnas.97.4.1456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.4.1456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.4.1456%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460%26doi%3D10.1073%2Fpnas.97.4.1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Soluble protein oligomers in neurodegeneration: Lesson from the Alzheimer’s amyloid β-peptide</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1038/nrm2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnrm2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=17245412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=101-112&author=C.+Haassauthor=D.+J.+Selkoe&title=Soluble+protein+oligomers+in+neurodegeneration%3A+Lesson+from+the+Alzheimer%E2%80%99s+amyloid+%CE%B2-peptide&doi=10.1038%2Fnrm2101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide</span></div><div class="casAuthors">Haass, Christian; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders.  Small intermediates - sol. oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insol. deposits might function as reservoirs of the bioactive oligomers.  These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and plasticity.  Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmPK-IDaBZirVg90H21EOLACvtfcHk0lg5YqEJMuRYdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D&md5=e8634ff5c1491580f623c90ded91b4be</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2101%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSoluble%2520protein%2520oligomers%2520in%2520neurodegeneration%253A%2520Lesson%2520from%2520the%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520%25CE%25B2-peptide%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D101%26epage%3D112%26doi%3D10.1038%2Fnrm2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D. J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0lg5YqEJMuRYdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blain, J.-F.</span></span> <span> </span><span class="NLM_article-title">Gamma secretase modulators: New Alzheimer’s drugs on the horizon?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7389</span>– <span class="NLM_lpage">7409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01960</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01960" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7389-7409&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=J.-F.+Blain&title=Gamma+secretase+modulators%3A+New+Alzheimer%E2%80%99s+drugs+on+the+horizon%3F&doi=10.1021%2Facs.jmedchem.5b01960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Blain, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7389-7409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The rapidly aging population desperately requires new therapies for Alzheimer's disease.  Despite years of pharmaceutical research, limited clin. success has been realized, with several failed disease modification therapies in recent years.  On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its prodn.  In this Perspective, we focus on the development of small mols. that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concn. of the shorter non-amyloidogenic Aβ species.  After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clin. proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEjGJ5oHdrrVg90H21EOLACvtfcHk0lg5YqEJMuRYdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D&md5=8ba1b7de2ce64903c296b7cb63c1c5d3</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DBlain%26aufirst%3DJ.-F.%26atitle%3DGamma%2520secretase%2520modulators%253A%2520New%2520Alzheimer%25E2%2580%2599s%2520drugs%2520on%2520the%2520horizon%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7389%26epage%3D7409%26doi%3D10.1021%2Facs.jmedchem.5b01960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgmns1ApCmxlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lgmns1ApCmxlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>, DOI: <span class="refDoi"> DOI: 10.1016/B978-0-12-409547-2.13809-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-Secretase%2520%2528BACE%2529%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383%26doi%3D10.1016%2FB978-0-12-409547-2.13809-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhoSz-lJdo0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure+based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure%2520based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0lhoSz-lJdo0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstroem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soederman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundstroem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotticci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öhberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgievska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9346</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstroemauthor=S.+von+Bergauthor=P.+Soedermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstroemauthor=M.+Sundstroemauthor=D.+Turekauthor=J.+Kihlstroemauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketjaellauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+Faelting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0liA8HPOWa60mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstroem%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DSoederman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstroem%26aufirst%3DJ.%26aulast%3DSundstroem%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstroem%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: Conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+Conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9eR"><div class="casContent"><span class="casTitleNuber">9e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0liA8HPOWa60mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520Conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0lgRMDmWpf6gtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhchan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): Identification of (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9831</span>, <span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+Identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%B2H-spiro%5Bchromeno%5B2%2C3-b%5Dpyridine-5%2C4%E2%80%B2-oxazol%5D-2%E2%80%B2-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)</span></div><div class="casAuthors">Dineen, Thomas A.; Chen, Kui; Cheng, Alan C.; Derakhchan, Katayoun; Epstein, Oleg; Esmay, Joel; Hickman, Dean; Kreiman, Chuck E.; Marx, Isaac E.; Wahl, Robert C.; Wen, Paul H.; Weiss, Matthew M.; Whittington, Douglas A.; Wood, Stephen; Fremeau, Robert T.; White, Ryan D.; Patel, Vinod F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9811-9831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compds. exhibited potential hERG liabilities.  In this article, we describe 4-aza substitution on the xanthene core as a means to increase BACE1 potency while reducing hERG binding affinity.  Further optimization of the P3 and P2' side chains resulted in the identification of 42 (AMG-8718), a compd. with a balanced profile of BACE1 potency, hERG binding affinity, and Pgp recognition.  This compd. produced robust and sustained redns. of CSF and brain Aβ levels in a rat pharmacodynamic model and exhibited significantly reduced potential for QTc elongation in a cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDPCl7cW3IyLVg90H21EOLACvtfcHk0lgRMDmWpf6gtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrP&md5=4c586d61f5ba555948eed2c27b728fbb</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520Identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0lj6KBsIUJH2tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.g</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.g+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lj6KBsIUJH2tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.g%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span>; <span class="NLM_string-name">McKittrick, B.</span>; <span class="NLM_string-name">Sun, Z.-Y.</span>; <span class="NLM_string-name">Yuanzan, C.</span>; <span class="NLM_string-name">Voigt, J.
H.</span>; <span class="NLM_string-name">Strickland, C.</span>; <span class="NLM_string-name">Smith, E.
M.</span>; <span class="NLM_string-name">Stamford, A.</span>; <span class="NLM_string-name">Greenlee, W. J.</span>; <span class="NLM_string-name">Iserloh, U.</span>; <span class="NLM_string-name">Mazzola, R.</span>; <span class="NLM_string-name">Caldwell, J.</span>; <span class="NLM_string-name">Cumming, J.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Gua, T.</span>; <span class="NLM_string-name">Le, T. X. H.</span>; <span class="NLM_string-name">Saionz, K. W.</span>; <span class="NLM_string-name">Babu, S. D.</span>; <span class="NLM_string-name">Hunter, R.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Aspartyl Protease Inhibitors</span>. <span class="NLM_patent">WO2005058311 A1</span>, June 30, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=Z.+Zhu&author=B.+McKittrick&author=Z.-Y.+Sun&author=C.+Yuanzan&author=J.%0AH.+Voigt&author=C.+Strickland&author=E.%0AM.+Smith&author=A.+Stamford&author=W.+J.+Greenlee&author=U.+Iserloh&author=R.+Mazzola&author=J.+Caldwell&author=J.+Cumming&author=L.+Wang&author=T.+Gua&author=T.+X.+H.+Le&author=K.+W.+Saionz&author=S.+D.+Babu&author=R.+Hunter&title=Heterocyclic+Aspartyl+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DHeterocyclic%2520Aspartyl%2520Protease%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span>; <span class="NLM_string-name">Erdei, J. J.</span>; <span class="NLM_string-name">Gunawan, I. S.</span>; <span class="NLM_string-name">Zhou, P.</span>; <span class="NLM_string-name">Yan, Y.</span>; <span class="NLM_string-name">Quagliato, D. A.</span></span> <span> </span><span class="NLM_article-title">Amino-5,5-diphenylimidazolone Derivatives for the Inhibition of Beta-Secretase</span>. <span class="NLM_patent">US20050282825</span>, December 22, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+S.+Malamas&author=J.+J.+Erdei&author=I.+S.+Gunawan&author=P.+Zhou&author=Y.+Yan&author=D.+A.+Quagliato&title=Amino-5%2C5-diphenylimidazolone+Derivatives+for+the+Inhibition+of+Beta-Secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26atitle%3DAmino-5%252C5-diphenylimidazolone%2520Derivatives%2520for%2520the%2520Inhibition%2520of%2520Beta-Secretase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgAoYBgtWYGDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lgAoYBgtWYGDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lhfA5F4OXwuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=X.+Chenauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=E.+M.+Parkerauthor=A.+W.+Stamfordauthor=J.+N.+Cummingauthor=W.+Liauthor=J.+D.+Scottauthor=K.+Coxauthor=M.+F.+Dockendorfauthor=H.+J.+Kleijnauthor=H.+Meiauthor=J.+A.+Stoneauthor=M.+Eganauthor=L.+Ereshefskyauthor=S.+Jheeauthor=B.+A.+Mattsonauthor=J.+Palczaauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_label">(a) </span>Details of elenbecestat are given at Alzforum website. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details+of+elenbecestat+are+given+at+Alzforum+website.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span>The structure
of elenbecestat can be found at PubChem website. <a href="https://pubchem.ncbi.nlm.nih.gov/compound/57827330#section=Top" class="extLink">https://pubchem.ncbi.nlm.nih.gov/compound/57827330#section=Top</a> (accessed May 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+structure%0Aof+elenbecestat+can+be+found+at+PubChem+website.+https%3A%2F%2Fpubchem.ncbi.nlm.nih.gov%2Fcompound%2F57827330%23section%3DTop+%28accessed+May+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">A predicted structure of RG-7129 is given in ref <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebers&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjaell, Susanna; Janson, Juliette; Kaspersson, Karin; Bogstedt, Anna; Jeppsson, Fredrik; Faelting, Johanna; Haeberlein, Samantha Budd; Kugler, Alan R.; Alexander, Robert C.; Cebers, Gvido; Ho, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1123</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A growing body of pathol., biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in prodn., processing, and/or clearance of brain amyloid-β peptide (Aβ) concns., plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the sol. N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the prodn. of Aβ.  Here, we report the in vitro and in vivo pharmacol. profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent redns. in plasma, cerebrospinal fluid, and brain concns. of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concns. in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the obsd. effect beyond the turnover rate of Aβ.  The preclin. data strongly support the clin. development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMi27mSRG67Vg90H21EOLACvtfcHk0liSuO9IN409tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D&md5=6d022dd410874469f2fce43d463bd63c</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> Details of CNP520 are given at Alzforum
Web site. <a href="http://www.alzforum.org/therapeutics/cnp520" class="extLink">http://www.alzforum.org/therapeutics/cnp520</a> (accessed September
10, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Details+of+CNP520+are+given+at+Alzforum%0AWeb+site.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fcnp520+%28accessed+September%0A10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dement. (N. Y.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=29067308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2eYMQCAWVqVDebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dement.%2520%2528N.%2520Y.%2529%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Of these seven clinical compounds, clinical studies of LY-2811376, LY-2886721, and RG-7129 were discontinued due to adverse findings observed in a preclinical 3-month rat toxicology study, abnormal liver enzyme elevations in a phase II study, and unknown reasons, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Aminodihydrothiazine Derivatives as β-Secretase Inhibitors</span>. <span class="NLM_patent">WO2007049532 A1</span>, March 5, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Aminodihydrothiazine+Derivatives+as+%CE%B2-Secretase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-Aminodihydrothiazine%2520Derivatives%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitors: A head group scan on a series of amides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4239</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+A+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0lhC-Cm-F4M26w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520A%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lhC-Cm-F4M26w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>Related comments can be
found in ref <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> or
at the following Web site<a href="http://www.alzforum.org/therapeutics/rg7129" class="extLink">http://www.alzforum.org/therapeutics/rg7129</a> (accessed June 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Related+comments+can+be%0Afound+in+ref+%288b%29+or%0Aat+the+following+Web+sitehttp%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Frg7129+%28accessed+June+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS Drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+Drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lhC-Cm-F4M26w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520Drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0li-txO21eDqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Most of the compounds used in the data set were described in ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>. We analyzed 70 compounds with BACE1 IC<sub>50</sub> of <100 nM and experimental p<i>K</i><sub>a</sub> values, which were submitted at the start of this research.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span> <i>ACD/Percepta</i>, version <span class="NLM_edition">14.0.0</span> (build
2726); <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Ontario, Canada</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ACD%2FPercepta%2C+version+14.0.0+%28build%0A2726%29%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Ontario%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FPercepta%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dammer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1186/s40035-015-0041-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1186%2Fs40035-015-0041-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=26448863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=18&author=Y.-B.+Huauthor=E.+B.+Dammerauthor=R.-J.+Renauthor=G.+Wang&title=The+endosomal-lysosomal+system%3A+from+acidification+and+cargo+sorting+to+neurodegeneration&doi=10.1186%2Fs40035-015-0041-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span></div><div class="casAuthors">Hu, Yong-Bo; Dammer, Eric B.; Ren, Ru-Jing; Wang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/10</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The endosomal-lysosomal system is made up of a set of intracellular membranous compartments that dynamically interconvert, which is comprised of early endosomes, recycling endosomes, late endosomes, and the lysosome.  In addn., autophagosomes execute autophagy, which delivers intracellular contents to the lysosome.  Maturation of endosomes and/or autophagosomes into a lysosome creates an unique acidic environment within the cell for proteolysis and recycling of unneeded cellular components into usable amino acids and other biomol. building blocks.  In the endocytic pathway, gradual maturation of endosomes into a lysosome and acidification of the late endosome are accompanied by vesicle trafficking, protein sorting and targeted degrdn. of some sorted cargo.  Two opposing sorting systems are operating in these processes: the endosomal sorting complex required for transport (ESCRT) supports targeted degrdn. and the retromer supports retrograde retrieval of certain cargo.  The endosomal-lysosomal system is emerging as a central player in a host of neurodegenerative diseases, demonstrating potential roles which are likely to be revealed in pathogenesis and for viable therapeutic strategies.  Here we focus on the physiol. process of endosomal-lysosomal maturation, acidification and sorting systems along the endocytic pathway, and further discuss relationships between abnormalities in the endosomal-lysosomal system and neurodegenerative diseases, esp. Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sz_jogdArVg90H21EOLACvtfcHk0li-txO21eDqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D&md5=819113d11b363b56845873309c4219ef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs40035-015-0041-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-015-0041-1%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.-B.%26aulast%3DDammer%26aufirst%3DE.%2BB.%26aulast%3DRen%26aufirst%3DR.-J.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DThe%2520endosomal-lysosomal%2520system%253A%2520from%2520acidification%2520and%2520cargo%2520sorting%2520to%2520neurodegeneration%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2015%26volume%3D4%26spage%3D18%26doi%3D10.1186%2Fs40035-015-0041-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterases: structure, function and polymorphism in mammals</span>. <i>J. Pestic. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1584/jpestics.R10-02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1584%2Fjpestics.R10-02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKit7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=218-228&author=T.+Satohauthor=M.+Hosokawa&title=Carboxylesterases%3A+structure%2C+function+and+polymorphism+in+mammals&doi=10.1584%2Fjpestics.R10-02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylesterases: structure, function and polymorphism in mammals</span></div><div class="casAuthors">Satoh, Tetsuo; Hosikawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pesticide Science (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-228</span>CODEN:
                <span class="NLM_cas:coden">JPSTCF</span>;
        ISSN:<span class="NLM_cas:issn">1348-589X</span>.
    
            (<span class="NLM_cas:orgname">Pesticide Science Society of Japan</span>)
        </div><div class="casAbstract">A review.  This review covers current developments in mol.-based studies of the structure and function of carboxylesterases.  To allay the confusion of the classic classification of carboxylesterase isoenzymes, we propose a novel nomenclature and classification of mammalian carboxylesterases on the basis of mol. properties.  Mechanisms of the regulation of the gene expression of carboxylesterases by xenobiotics, and the involvement of carboxylesterase in drug metab. are also described.  The novel biomarker for organophosphate pesticide exposure developed here is much more useful and reliable than cholinesterase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8znkT2c2B9LVg90H21EOLACvtfcHk0li-txO21eDqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKit7jN&md5=956d777136501f3f5488bbd50c1d2f1c</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1584%2Fjpestics.R10-02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1584%252Fjpestics.R10-02%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DCarboxylesterases%253A%2520structure%252C%2520function%2520and%2520polymorphism%2520in%2520mammals%26jtitle%3DJ.%2520Pestic.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D218%26epage%3D228%26doi%3D10.1584%2Fjpestics.R10-02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterase Isozymes: catalytic properties and rational drug design</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.2133/dmpk.21.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.2133%2Fdmpk.21.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=16858120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Siu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=173-185&author=T.+Imai&title=Human+Carboxylesterase+Isozymes%3A+catalytic+properties+and+rational+drug+design&doi=10.2133%2Fdmpk.21.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase Isozymes: catalytic properties and rational drug design</span></div><div class="casAuthors">Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Human carboxylesterase 1 (hCE-1, CES1A1, HU1) and carboxylesterase 2 (hCE-2, hiCE, HU3) are a serine esterase involved in both drug metab. and activation.  Although both hCE-1 and hCE-2 are present in several organs, the hydrolase activity of liver and small intestine is predominantly attributed to hCE-1 and hCE-2, resp.  The substrate specificity of hCE-1 and hCE-2 is significantly different.  HCE-1 mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active pocket sometimes allows it to act on structurally distinct compds. of either large or small alc. moiety.  In contrast, hCE-2 recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by a capability of acyl-hCE-2 conjugate formation due to the presence of conformational interference in the active pocket.  Furthermore, hCE-1 shows high transesterification activity, esp. with hydrophobic alc., but negligible for hCE-2.  Transesterification may be a reason for the substrate specificity of hCE-1 that hardly hydrolyzes a substrate with hydrophobic alc. group, because transesterification can progress at the same time when a compd. is hydrolyzed by hCE-1.  From the standpoint of drug absorption, the intestinal hydrolysis by CES during drug absorption is evaluated in rat intestine and Caco2-cell line.  The rat in situ single-pass perfusion shows markedly extensive hydrolysis in the intestinal mucosa.  Since the hydrolyzed products are present at higher concn. in the epithelial cells rather than blood vessels and intestinal lumen, hydrolyzates are transported by a specific efflux transporter and passive diffusion according to pH-partition.  The expression pattern of CES in Caco-2 cell monolayer, a useful in vitro model for rapid screening of human intestinal drug absorption, is completely different from that in human small intestine but very similar to human liver that expresses a much higher level of hCE-1 and lower level of hCE-2.  Therefore, the prediction of human intestinal absorption using Caco-2 cell monolayers should be carefully monitored in the case of ester and amide-contg. drugs such as prodrugs.  Further experimentation for an understanding of detailed substrate specificity for CES and development of in vitro evaluation systems for absorption of prodrug and its hydrolyzates will help us to design the ideal prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppSsuxleoMALVg90H21EOLACvtfcHk0liBQz_bq5oUEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Siu74%253D&md5=45b914a8c7db6e411522f202501a446d</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.173%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26atitle%3DHuman%2520Carboxylesterase%2520Isozymes%253A%2520catalytic%2520properties%2520and%2520rational%2520drug%2520design%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D173%26epage%3D185%26doi%3D10.2133%2Fdmpk.21.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">The chemical name of the aniline is (<i>S</i>)-4-(5-amino-2-fluorophenyl)-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine dihydrochloride.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasman, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J-.H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahematpura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1124%2Fdmd.104.001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=15502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+C.+A.+Hopauthor=I.+N.+Kasmanauthor=J.+LaPerleauthor=J-.H.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=D.+Vanauthor=W.+Jeffreyauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+Evaluation+using+the+MDR1A%2F1B+knockout+mouse+model&doi=10.1124%2Fdmd.104.001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span></div><div class="casAuthors">Doran, Angela; Obach, R. Scott; Smith, Bill J.; Hosea, Natilie A.; Becker, Stacey; Callegari, Ernesto; Chen, Cuiping; Chen, Xi; Choo, Edna; Cianfrogna, Julie; Cox, Loretta M.; Gibbs, John P.; Gibbs, Megan A.; Hatch, Heather; Hop, Cornelis E. C. A.; Kasman, Ilana N.; LaPerle, Jennifer; Liu, JianHua; Liu, Xingrong; Logman, Michael; Maclin, Debra; Nedza, Frank M.; Nelson, Frederick; Olson, Emily; Rahematpura, Sandhya; Raunig, David; Rogers, Sabrinia; Schmidt, Kari; Spracklin, Douglas K.; Szewc, Mark; Troutman, Matthew; Tseng, Elaine; Tu, Meihua; Van Deusen, Jeffrey W.; Venkatakrishnan, Karthik; Walens, Gary; Wang, Ellen Q.; Wong, Diane; Yasgar, Adam S.; Zhang, Chenghong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two structurally diverse drugs used for the treatment of various conditions of the central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs were measured in brain, plasma, and cerebrospinal fluid in the P-glycoprotein (P-gp) knockout mouse model after s.c. administration, and the data were compared with corresponding data obtained in wild-type mice.  Total brain-to-plasma (B/P) ratios for the CNS agents ranged from 0.060 to 24.  Of the 34 CNS-active agents, only 7 demonstrated B/P area under the plasma concn. curve ratios between P-gp knockout and wild-type mice that did not differ significantly from unity.  Most of the remaining drugs demonstrated 1.1- to 2.6-fold greater B/P ratios in P-gp knockout mice vs. wild-type mice.  Three, risperidone, its active metabolite 9-hydroxyrisperidone, and metoclopramide, showed marked differences in B/P ratios between knockout and wild-type mice (6.6- to 17-fold).  Differences in B/P ratios and cerebrospinal fluid/plasma ratios between wild-type and knockout animals were correlated.  Through the use of this model, it appears that most CNS-active agents demonstrate at least some P-gp-mediated transport that can affect brain concns.  However, the impact for the majority of agents is probably minor.  The example of risperidone illustrates that even good P-gp substrates can still be clin. useful CNS-active agents.  However, for such agents, unbound plasma concns. may need to be greater than values projected using receptor affinity data to achieve adequate receptor occupancy for effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCLikZvvYtAbVg90H21EOLACvtfcHk0liBQz_bq5oUEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D&md5=58acf489206dfeaaa96da4329e403710</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001230%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ-.H.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520Evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174%26doi%3D10.1124%2Fdmd.104.001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>The ICR
mice were obtained from Charles River Laboratories Japan, Inc., Yokohama,
Japan. <a href="http://www.crj.co.jp/product/domestic/detail/37" class="extLink">http://www.crj.co.jp/product/domestic/detail/37</a> (accessed March
4, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+ICR%0Amice+were+obtained+from+Charles+River+Laboratories+Japan%2C+Inc.%2C+Yokohama%2C%0AJapan.+http%3A%2F%2Fwww.crj.co.jp%2Fproduct%2Fdomestic%2Fdetail%2F37+%28accessed+March%0A4%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1inhibition in a dog model</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=23948925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-%CE%B2+peptides+in+cerebrospinal+fluid+after+BACE1inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model</span></div><div class="casAuthors">Borghys Herman; Jacobs Tom; Van Broeck Bianca; Dillen Lieve; Dhuyvetter Deborah; Gijsen Harrie; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beta-secretase is the first cleavage enzyme of amyloid-β protein precursor (AβPP) in the amyloidogenic pathway, leading to the formation of the plaque forming Amyloid-β (Aβ)1-42 peptide.  BACE (beta-site AβPP cleaving enzyme) 1 inhibition is therefore considered to be a promising disease modifying therapy for Alzheimer's disease.  An early assessment of the in vivo activity of BACE inhibitors was done in dogs since AβPP processing is the same as in humans and this species easily enables longitudinal cerebrospinal fluid (CSF) sampling.  Aβ changes in CSF compared to baseline are used to evaluate target engagement of the compounds.  Levels of Aβ1-37, Aβ1-38, Aβ1-40, and Aβ1-42 in CSF are measured with immunoassay (Mesoscale electrochemiluminescence technology) and with an ultra high-performance liquid chromatography mass spectrometry (UPLC-MS/MS).  Two experimental BACE inhibitors were evaluated.  With the immunoassay, a dose dependent decrease is observed for all four Aβ peptides.  Measurements with the UPLC-MS/MS are in line with the immunoassay for Aβ1-37, Aβ1-38, and Aβ1-40, however, for Aβ1-42, differences are sometimes observed when comparing to changes seen in the other peptides with UPLC-MS/MS and with immunoassay results.  Generally lower concentrations are measured with immunoassay.  The reason for these differences is still unknown.  Aβ1-42 is more prone to form aggregates compared to the other peptides.  One hypothesis could be that while the immunoassay only measures free Aβ, bound and aggregated Aβ peptides are at least partially dissolved with the UPLC-MS/MS method, since acetonitrile is added to the CSF samples.  This increases variability in the concentration of Aβ peptide measured with UPLC-MS/MS, especially for Aβ1-42, potentially masking the compound effect on Aβ1-42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMHtlzo9xastyfW6udTcc2eYeZ2gN7zqM-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVOqug%253D%253D&md5=12cfea7618a0e7d052b1488f38548e60</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-%25CE%25B2%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Head, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarsoza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayed, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studzinski, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-1397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-2010-1397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=20164551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFWjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=637-646&author=E.+Headauthor=V.+Popauthor=F.+Sarsozaauthor=R.+Kayedauthor=T.+L.+Beckettauthor=C.+M.+Studzinskiauthor=J.+L.+Tomicauthor=C.+G.+Glabeauthor=M.+P.+Murphy&title=Amyloid-%CE%B2+peptide+and+oligomers+in+the+brain+and+cerebrospinal+fluid+of+aged+canines&doi=10.3233%2FJAD-2010-1397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Peptide and Oligomers in the Brain and Cerebrospinal Fluid of Aged Canines</span></div><div class="casAuthors">Head, Elizabeth; Pop, Viorela; Sarsoza, Floyd; Kayed, Rakez; Beckett, Tina L.; Studzinski, Christa M.; Tomic, Jennifer L.; Glabe, Charles G.; Murphy, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-646</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amt. of amyloid pathol. in the brain.  Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function.  However, the type and quantity of biochem. extd. Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examd. systematically.  Thirty beagles, aged 4.5-15.7 years, were studied.  Aβ40 and Aβ42 were measured in CSF by ELISA, and from SDS and formic acid extd. prefrontal cortex.  A sample of the contralateral hemisphere, used to assess immunohistochem. amyloid load, was used for comparison.  In the brain, increases in Aβ42 were detected at a younger age, prior to increases in Aβ40, and were correlated with an increased amyloid load.  In the CSF, Aβ42 decreased with age while Aβ40 levels remained const.  The CSF Aβ42/40 ratio was also a good predictor of the amt. of Aβ in the brain.  The amt. of sol. oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS sol. Aβ42.  These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain.  These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathol. and is a potentially useful model for the refinement of therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqGuadzTdJZrVg90H21EOLACvtfcHk0liCxgEzWQUEqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFWjsb8%253D&md5=c0442f9de72f8fdd88458d3da75a8dfd</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1397%26sid%3Dliteratum%253Aachs%26aulast%3DHead%26aufirst%3DE.%26aulast%3DPop%26aufirst%3DV.%26aulast%3DSarsoza%26aufirst%3DF.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DBeckett%26aufirst%3DT.%2BL.%26aulast%3DStudzinski%26aufirst%3DC.%2BM.%26aulast%3DTomic%26aufirst%3DJ.%2BL.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DAmyloid-%25CE%25B2%2520peptide%2520and%2520oligomers%2520in%2520the%2520brain%2520and%2520cerebrospinal%2520fluid%2520of%2520aged%2520canines%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D637%26epage%3D646%26doi%3D10.3233%2FJAD-2010-1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">The tert-butanesulfinyl group: an ideal chiral directing group and Boc-surrogate for the asymmetric synthesis and applications of β-amino acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1021/jo9820824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9820824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1cXotVCrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=12-13&author=T.+P.+Tangauthor=J.+A.+Ellman&title=The+tert-butanesulfinyl+group%3A+an+ideal+chiral+directing+group+and+Boc-surrogate+for+the+asymmetric+synthesis+and+applications+of+%CE%B2-amino+acids&doi=10.1021%2Fjo9820824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-Butanesulfinyl Group: An Ideal Chiral Directing Group and Boc-Surrogate for the Asymmetric Synthesis and Applications of β-Amino Acids</span></div><div class="casAuthors">Tang, Tony P.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-13</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The utility of tert-butanesulfinamide [i.e., [S(R)]-2-methyl-2-propanesulfinamide derivs.] in the chiral synthesis of β-amino acids was demonstrated.  The condensation of [S(R)]-2-methyl-2-propanesulfinamide with carbonyl compds. gave the corresponding sulfinyl imines.  The diastereofacial selectivity of these imines toward lithium or titanium enolate addn. was studied.  One of the compds. thus prepd. was converted into (-)-N-[N-[[[4-(aminoiminomethyl)phenyl]amino]carbonyl]-3-(3-pyridinyl)-β-alanyl]-β-alanine Et ester, which is a precursor for a known GPIIbIIIa antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9TX5d-94zObVg90H21EOLACvtfcHk0liCxgEzWQUEqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVCrsrk%253D&md5=76a1845d086069a408d2027c68c1321a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjo9820824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9820824%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520tert-butanesulfinyl%2520group%253A%2520an%2520ideal%2520chiral%2520directing%2520group%2520and%2520Boc-surrogate%2520for%2520the%2520asymmetric%2520synthesis%2520and%2520applications%2520of%2520%25CE%25B2-amino%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D12%26epage%3D13%26doi%3D10.1021%2Fjo9820824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, E. M.</span></span> <span> </span><span class="NLM_article-title">The reactions of an N-sulfonylamine inner salt</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">4744</span>– <span class="NLM_lpage">4745</span>, <span class="refDoi"> DOI: 10.1021/ja01019a052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01019a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaF1cXltVKlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=4744-4745&author=G.+M.+Atkinsauthor=E.+M.+Burgess&title=The+reactions+of+an+N-sulfonylamine+inner+salt&doi=10.1021%2Fja01019a052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The reactions of an N-sulfonylamine inner salt</span></div><div class="casAuthors">Atkins, George M., Jr.; Burgess, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4744-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Cryst. ethyl(carboxysulfamoyl)triethylammonium hydroxide, EtO2CN-SO2N+Et3 (I), was prepd. by treating Et2OCNHSO2Cl with Et3N in C6H6 and the various reactions of I were studied.  Treating a C6H6 soln. of I with PhNH2, 2-propanol, or PhNMe2 yielded EtO2CNHSO2NHPh, EtO2CNHSO2OCHMe2, or N,N-dimethyl-N'-carbethoxysulfanilamide, resp.  The electrophilic addn. of I to N-vinylpyrolidinone yielded N-(2-carbethoxyamidosulfonylvinyl)pyrrolidone.  Treating I in MeCN with tetramethylallene yielded a 5-1 mixt. of 2,3-dihydro-2,2-dimethyl-3-isopropylidene-6-ethoxy-1,4,5-oxathiazine 4,4-dioxide and 2-carbethoxy-3,3-dimethyl-4-isopropylidene-1,2-thiazetidine 1,1-dioxide.  Treating I with hexamethylbicyclo[2.2.0]hexa-2,5-diene yielded the 1-1 cycloadduct II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcfVN2fKPhrVg90H21EOLACvtfcHk0lgR5_R_VIWsaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXltVKlurw%253D&md5=748b54624f45f4da1cac6037c91b7f27</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja01019a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01019a052%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DG.%2BM.%26aulast%3DBurgess%26aufirst%3DE.%2BM.%26atitle%3DThe%2520reactions%2520of%2520an%2520N-sulfonylamine%2520inner%2520salt%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D4744%26epage%3D4745%26doi%3D10.1021%2Fja01019a052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f','cit9g','cit9h','cit9i'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14','cit14b'],'ref15':[],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':[],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Shuhei Yoshida, Genta Tadano, Naoya Asada, Kouki Fuchino, Shinji Suzuki, Eriko Matsuoka, Takahiko Yamamoto, Shiho Yamamoto, Shigeru Ando, Naoki Kanegawa, Yutaka Tonomura, Hisanori Ito, Diederik Moechars, Frederik J. R. Rombouts, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3075-3085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BImproving%252BSelectivity%252Bthrough%252BUtilizing%252BExplicit%252BWater%252BMolecules%25253A%252BDiscovery%252Bof%252BSelective%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuji Koriyama, Akihiro Hori, Hisanori Ito, Shuji Yonezawa, Yoshiyasu Baba, Norihiko Tanimoto, Tatsuhiko Ueno, Shiho Yamamoto, Takahiko Yamamoto, Naoya Asada, Kenji Morimoto, Shunsuke Einaru, Katsunori Sakai, Takushi Kanazu, Akihiro Matsuda, Yoshitaka Yamaguchi, Takuya Oguma, Maarten Timmers, Luc Tritsmans, Ken-ichi Kusakabe, Akira Kato, <span class="NLM_string-name hlFld-ContribAuthor">Gaku Sakaguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1873-1888. <a href="https://doi.org/10.1021/acs.jmedchem.0c01917" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAtabecestat%252B%252528JNJ-54861911%252529%25253A%252BA%252BThiazine-Based%252B%2525CE%2525B2-Amyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252BAdvanced%252Bto%252Bthe%252BPhase%252B2b%25252F3%252BEARLY%252BClinical%252BTrial%26aulast%3DKoriyama%26aufirst%3DYuji%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05112020%26date%3D15022021%26volume%3D64%26issue%3D4%26spage%3D1873%26epage%3D1888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeffery Richardson, Peter J. Lindsay-Scott, Vladimir Larichev, <span class="NLM_string-name hlFld-ContribAuthor">Emily Pocock</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Method for the Synthesis of Amino-1,3-Oxazines from Thioureas. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (12)
                                     , 2853-2863. <a href="https://doi.org/10.1021/acs.oprd.0c00369" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00369%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEfficient%252BMethod%252Bfor%252Bthe%252BSynthesis%252Bof%252BAmino-1%25252C3-Oxazines%252Bfrom%252BThioureas%26aulast%3DRichardson%26aufirst%3DJeffery%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D24112020%26volume%3D24%26issue%3D12%26spage%3D2853%26epage%3D2863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Genta Tadano, Kazuo Komano, Shuhei Yoshida, Shinji Suzuki, Kenji Nakahara, Kouki Fuchino, Kazuki Fujimoto, Eriko Matsuoka, Takahiko Yamamoto, Naoya Asada, Hisanori Ito, Gaku Sakaguchi, Naoki Kanegawa, Yasuto Kido, Shigeru Ando, Tamio Fukushima, Ard Teisman, Vijay Urmaliya, Deborah Dhuyvetter, Herman Borghys, An Van Den Bergh, Nigel Austin, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9331-9337. <a href="https://doi.org/10.1021/acs.jmedchem.9b01140" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BExtremely%252BPotent%252BThiazine-Based%252B%2525CE%2525B2-Secretase%252BInhibitor%252Bwith%252BReduced%252BCardiovascular%252Band%252BLiver%252BToxicity%252Bat%252Ba%252BLow%252BProjected%252BHuman%252BDose%26aulast%3DTadano%26aufirst%3DGenta%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14072019%26date%3D08102019%26date%3D24092019%26volume%3D62%26issue%3D20%26spage%3D9331%26epage%3D9337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Genta Tadano, Takahiko Yamamoto, Kenji Nakahara, Kouki Fuchino, Hisanori Ito, Naoki Kanegawa, Diederik Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5080-5095. <a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BSelective%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BTargeting%252Bthe%252BFlap%252Bto%252BGain%252BSelectivity%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16022019%26date%3D13052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Takuya Oguma, Kosuke Anan, Shinji Suzuki, Shinya Hisakawa, Akihiro Takada, Masayoshi Ogawa, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a 6-CF3-Substituted 2-Amino-dihydro-1,3-thiazine β-Secretase Inhibitor by N,N-Diethylaminosulfur Trifluoride-Mediated Chemoselective Cyclization. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4893-4897. <a href="https://doi.org/10.1021/acs.joc.8b02179" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02179%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252B6-CF3-Substituted%252B2-Amino-dihydro-1%25252C3-thiazine%252B%2525CE%2525B2-Secretase%252BInhibitor%252Bby%252BN%25252CN-Diethylaminosulfur%252BTrifluoride-Mediated%252BChemoselective%252BCyclization%26aulast%3DOguma%26aufirst%3DTakuya%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23082018%26date%3D29102018%26date%3D12102018%26volume%3D84%26issue%3D8%26spage%3D4893%26epage%3D4897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5525-5546. <a href="https://doi.org/10.1021/acs.jmedchem.8b00011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BCentrally%252BActive%252B6-Substituted%252B5-Fluoro-1%25252C3-dihydro-oxazine%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bvia%252BActive%252BConformation%252BStabilization%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D14062018%26date%3D18052018%26volume%3D61%26issue%3D13%26spage%3D5525%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenji  Nakahara</span>, <span class="hlFld-ContribAuthor ">Yasunori  Mitsuoka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kasuya</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Shiho  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Hisanori  Ito</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Balancing potency and basicity by incorporating fluoropyridine moieties: Discovery of a 1-amino-3,4-dihydro-2,6-naphthyridine BACE1 inhibitor that affords robust and sustained central Aβ reduction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113270. <a href="https://doi.org/10.1016/j.ejmech.2021.113270" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113270%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBalancing%252Bpotency%252Band%252Bbasicity%252Bby%252Bincorporating%252Bfluoropyridine%252Bmoieties%25253A%252BDiscovery%252Bof%252Ba%252B1-amino-3%25252C4-dihydro-2%25252C6-naphthyridine%252BBACE1%252Binhibitor%252Bthat%252Baffords%252Brobust%252Band%252Bsustained%252Bcentral%252BA%2525CE%2525B2%252Breduction%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2021%26volume%3D216%26spage%3D113270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristian  Privat</span>, <span class="hlFld-ContribAuthor ">José M.  Granadino-Roldán</span>, <span class="hlFld-ContribAuthor ">Jordi  Bonet</span>, <span class="hlFld-ContribAuthor ">Maria  Santos Tomas</span>, <span class="hlFld-ContribAuthor ">Juan J.  Perez</span>, <span class="hlFld-ContribAuthor ">Jaime  Rubio-Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment dissolved molecular dynamics: a systematic and efficient method to locate binding sites. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     , 3123-3134. <a href="https://doi.org/10.1039/D0CP05471B" title="DOI URL">https://doi.org/10.1039/D0CP05471B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CP05471B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CP05471B%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DFragment%252Bdissolved%252Bmolecular%252Bdynamics%25253A%252Ba%252Bsystematic%252Band%252Befficient%252Bmethod%252Bto%252Blocate%252Bbinding%252Bsites%26aulast%3DPrivat%26aufirst%3DCristian%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D4%26spage%3D3123%26epage%3D3134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kouki  Fuchino</span>, <span class="hlFld-ContribAuthor ">Moriyasu  Masui</span>, <span class="hlFld-ContribAuthor ">Shuhei  Yoshida</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Construction of an Amino-1,3-Oxazine Scaffold using Burgess Reagent Under Mild Conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>64 </em>, 152684. <a href="https://doi.org/10.1016/j.tetlet.2020.152684" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152684%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252BConstruction%252Bof%252Ban%252BAmino-1%25252C3-Oxazine%252BScaffold%252Busing%252BBurgess%252BReagent%252BUnder%252BMild%252BConditions%26aulast%3DFuchino%26aufirst%3DKouki%26date%3D2021%26volume%3D64%26spage%3D152684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Reichel</span>, <span class="hlFld-ContribAuthor ">Konstantin  Karaghiosoff</span>. </span><span class="cited-content_cbyCitation_article-title">Reagenzien für die selektive Fluormethylierung: Herausforderungen der Organofluorchemie. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (30)
                                     , 12364-12377. <a href="https://doi.org/10.1002/ange.201913175" title="DOI URL">https://doi.org/10.1002/ange.201913175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201913175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201913175%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DReagenzien%252Bf%2525C3%2525BCr%252Bdie%252Bselektive%252BFluormethylierung%25253A%252BHerausforderungen%252Bder%252BOrganofluorchemie%26aulast%3DReichel%26aufirst%3DMarco%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D30%26spage%3D12364%26epage%3D12377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Reichel</span>, <span class="hlFld-ContribAuthor ">Konstantin  Karaghiosoff</span>. </span><span class="cited-content_cbyCitation_article-title">Reagents for Selective Fluoromethylation: A Challenge in Organofluorine Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (30)
                                     , 12268-12281. <a href="https://doi.org/10.1002/anie.201913175" title="DOI URL">https://doi.org/10.1002/anie.201913175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201913175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201913175%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DReagents%252Bfor%252BSelective%252BFluoromethylation%25253A%252BA%252BChallenge%252Bin%252BOrganofluorine%252BChemistry%26aulast%3DReichel%26aufirst%3DMarco%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D30%26spage%3D12268%26epage%3D12281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies suggest the important role of interactions among the catalytic dyad and inhibitors for designing Bace1 specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127893. <a href="https://doi.org/10.1016/j.molstruc.2020.127893" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127893%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDocking%252Bstudies%252Bsuggest%252Bthe%252Bimportant%252Brole%252Bof%252Binteractions%252Bamong%252Bthe%252Bcatalytic%252Bdyad%252Band%252Binhibitors%252Bfor%252Bdesigning%252BBace1%252Bspecific%252Binhibitors%26aulast%3DYildiz%26aufirst%3DMuslum%26date%3D2020%26volume%3D1208%26spage%3D127893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldo  Peschiulli</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Harrie JM  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 126999. <a href="https://doi.org/10.1016/j.bmcl.2020.126999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3%25252C3-Difluoro-3%25252C4%25252C5%25252C6-tetrahydropyridin-2-amines%25253A%252BPotent%252Band%252Bpermeable%252BBACE-1%252Binhibitors%26aulast%3DPeschiulli%26aufirst%3DAldo%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D126999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Varnavas D.  Mouchlis</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Lefteris C.  Zacharia</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 703. <a href="https://doi.org/10.3390/ijms21030703" title="DOI URL">https://doi.org/10.3390/ijms21030703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21030703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21030703%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DComputer-Aided%252BDrug%252BDesign%252Bof%252B%2525CE%2525B2-Secretase%25252C%252B%2525CE%2525B3-Secretase%252Band%252BAnti-Tau%252BInhibitors%252Bfor%252Bthe%252BDiscovery%252Bof%252BNovel%252BAlzheimer%2525E2%252580%252599s%252BTherapeutics%26aulast%3DMouchlis%26aufirst%3DVarnavas%2BD.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D3%26spage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Lázár</span>, <span class="hlFld-ContribAuthor ">Ferenc  Fülöp</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Oxazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00008-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00008-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00008-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3-Oxazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DL%25C3%25A1z%25C3%25A1r%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhafer S.  Zinad</span>, <span class="hlFld-ContribAuthor ">Ahmed  Mahal</span>, <span class="hlFld-ContribAuthor ">Ranjan K.  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Ashish K.  Sarangi</span>, <span class="hlFld-ContribAuthor ">Mohammad Rizki Fadhil  Pratama</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of oxazines as promising agents in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (1)
                                     , 16-47. <a href="https://doi.org/10.1111/cbdd.13633" title="DOI URL">https://doi.org/10.1111/cbdd.13633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13633%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DMedicinal%252Bchemistry%252Bof%252Boxazines%252Bas%252Bpromising%252Bagents%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZinad%26aufirst%3DDhafer%2BS.%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D1%26spage%3D16%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kosuke  Anan</span>, <span class="hlFld-ContribAuthor ">Yasuyoshi  Iso</span>, <span class="hlFld-ContribAuthor ">Takuya  Oguma</span>, <span class="hlFld-ContribAuthor ">Kenji  Nakahara</span>, <span class="hlFld-ContribAuthor ">Shinji  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Eriko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Hisanori  Ito</span>, <span class="hlFld-ContribAuthor ">Gaku  Sakaguchi</span>, <span class="hlFld-ContribAuthor ">Shigeru  Ando</span>, <span class="hlFld-ContribAuthor ">Kenji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Naoki  Kanegawa</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Kawachi</span>, <span class="hlFld-ContribAuthor ">Tamio  Fukushima</span>, <span class="hlFld-ContribAuthor ">Ard  Teisman</span>, <span class="hlFld-ContribAuthor ">Vijay  Urmaliya</span>, <span class="hlFld-ContribAuthor ">Deborah  Dhuyvetter</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">An  Van Den Bergh</span>, <span class="hlFld-ContribAuthor ">Peter  Verboven</span>, <span class="hlFld-ContribAuthor ">Francois  Bischoff</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Yamano</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (22)
                                     , 1894-1910. <a href="https://doi.org/10.1002/cmdc.201900478" title="DOI URL">https://doi.org/10.1002/cmdc.201900478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900478%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTrifluoromethyl%252BDihydrothiazine%2525E2%252580%252590Based%252B%2525CE%2525B2%2525E2%252580%252590Secretase%252B%252528BACE1%252529%252BInhibitors%252Bwith%252BRobust%252BCentral%252B%2525CE%2525B2%2525E2%252580%252590Amyloid%252BReduction%252Band%252BMinimal%252BCovalent%252BBinding%252BBurden%26aulast%3DAnan%26aufirst%3DKosuke%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D22%26spage%3D1894%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Amidine-Based Clinical BACE1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. HTS Hit <b>4</b> and Initial Leads <b>5</b> and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. BACE1 Inhibitors <b>7</b>, <b>8</b>, and <b>9</b> Identified Utilizing a p<i>K</i><sub>a</sub>-Lowering Strategy</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of novel oxazine <b>B</b> from dihydrooxazine <b>A</b>. <sup><i>a</i></sup>The p<i>K</i><sub>a</sub> values were calculated with ACD/Percepta as the imine tautomer.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of the oxazine <b>15</b> bound to the active site of human BACE1 determined at 2.30 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY">5YGY</a>). Purple mesh shows |<i>F</i><sub>o</sub>| – |<i>F</i><sub>c</sub>| map contoured at 2.0σ in which ligand coordinates are omitted from the calculation. Key residues of the catalytic residues Asp228 and Asp32 (green), Tyr71 (purple) on the Flap region, and Gly230 (gray) are shown in stick style. Compound <b>15</b> is shown in ball-and-stick style with carbon atoms colored yellow. Nitrogen, oxygen, and fluorine atoms are colored blue, red, and sky blue, respectively. Dashed lines represent hydrogen bond interactions between <b>15</b> and BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Total Aβ reduction in mouse after an oral dose of <b>15</b> at 10 mg/kg (<i>n</i> = 4). Compound <b>15</b> was dosed as a solution of 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CSF Aβ1–40, and Aβ1–42 reduction in beagle dog after oral doses of <b>15</b> at 0.31, 1.25, and 5 mg/kg (<i>n</i> = 4). Compound <b>15</b> was dosed as a solution of 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxazine <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-2-methylpropane-2-sulfinamide, Ti(OEt)<sub>4</sub>, THF, 65 °C, 65%; (b) (i) Fe, NH<sub>4</sub>Cl, toluene–H<sub>2</sub>O, 80 °C, (ii) TFAA, Et<sub>3</sub>N, THF, – 25 °C, 78%; (c) allylmagnesium bromide, THF, – 78 °C, 40%; (d) O<sub>3</sub>, DCM, – 78 °C, 88%; (e) 2 N HCl in MeOH, rt, 56%; (f) triphosgene, Et<sub>3</sub>N, diallylamine, H<sub>2</sub>O–EtOAc, 0 °C, 82%; (g) (i) aq H<sub>2</sub>SO<sub>4</sub>, acetone, (ii) Burgess reagent, PPTS, THF, reflux, 24%; (h) K<sub>2</sub>CO<sub>3</sub>, THF–MeOH–H<sub>2</sub>O, 40 °C, 87%; (i) EDC, HOBt, DMAP, 5-cyanopicolinic acid, DMF, rt, 92%; (j) 1,3-dimethylbarbituric acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, DCM, reflux, 58%.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/medium/jm-2018-000029_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Oxazines <b>15</b> and <b>20</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00002/20180622/images/large/jm-2018-000029_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00002&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allylmagnesium bromide, Et<sub>2</sub>O, – 60 to −20 °C, 72%; (b) 4 N HCl in EtOAc, MeOH, 0 °C, quant; (c) 4-nitrophenyl chloroformate, K<sub>2</sub>CO<sub>3</sub>, bis(2,4-dimethoxybenzyl)amine, EtOAc–H<sub>2</sub>O, 0 °C to rt, 82%; (d) KMnO<sub>4</sub>, AcOH, acetone–H<sub>2</sub>O, rt, 68%; (e) (i) Ms<sub>2</sub>O, DCM, 0 °C, (ii) Burgess reagent, THF, rt, 40%; (f) NaI, acetone, rt, 95%; (g) AgF, MeCN, rt, 98%; (h) anisole, TFA, 80 °C, quant; (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>–TFA, – 20 °C, 94%; (j) Boc<sub>2</sub>O, DMAP, THF, 0 °C, 90%; (k) Fe, NH<sub>4</sub>Cl, EtOH–THF–H<sub>2</sub>O, 60 °C, 85%; (l) (i) HATU, RCO<sub>2</sub>H, DIEA, DCM, rt, (ii) HCO<sub>2</sub>H, rt, 61–95%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Wimo, A.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Ali, G.-C.</span>; <span class="NLM_string-name">Wu, Y.-T.</span>; <span class="NLM_string-name">Prina, M.</span></span> World Alzheimer Report 2015. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a> (accessed June 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prince%2C+M.%3B+Wimo%2C+A.%3B+Guerchet%2C+M.%3B+Ali%2C+G.-C.%3B+Wu%2C+Y.-T.%3B+Prina%2C+M.+World+Alzheimer+Report+2015.+https%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf+%28accessed+June+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lh6OXODg0Zadg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0ljns91ikcIxIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0ljns91ikcIxIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljns91ikcIxIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson-Croak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knops, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomensaari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1038/990114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2F990114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain&doi=10.1038%2F990114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540%26doi%3D10.1038%2F990114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloger, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingwall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-Secretase</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1006/mcne.1999.0811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-Secretase&doi=10.1006%2Fmcne.1999.0811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0liji54K9OpXZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-Secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427%26doi%3D10.1006%2Fmcne.1999.0811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2F990107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1456</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.4.1456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1073%2Fpnas.97.4.1456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein&doi=10.1073%2Fpnas.97.4.1456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.4.1456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.4.1456%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460%26doi%3D10.1073%2Fpnas.97.4.1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Soluble protein oligomers in neurodegeneration: Lesson from the Alzheimer’s amyloid β-peptide</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1038/nrm2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnrm2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=17245412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=101-112&author=C.+Haassauthor=D.+J.+Selkoe&title=Soluble+protein+oligomers+in+neurodegeneration%3A+Lesson+from+the+Alzheimer%E2%80%99s+amyloid+%CE%B2-peptide&doi=10.1038%2Fnrm2101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide</span></div><div class="casAuthors">Haass, Christian; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders.  Small intermediates - sol. oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insol. deposits might function as reservoirs of the bioactive oligomers.  These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and plasticity.  Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmPK-IDaBZirVg90H21EOLACvtfcHk0lg7RZH6EoTqZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D&md5=e8634ff5c1491580f623c90ded91b4be</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2101%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSoluble%2520protein%2520oligomers%2520in%2520neurodegeneration%253A%2520Lesson%2520from%2520the%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520%25CE%25B2-peptide%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D101%26epage%3D112%26doi%3D10.1038%2Fnrm2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D. J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0lhCgDesoN50GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blain, J.-F.</span></span> <span> </span><span class="NLM_article-title">Gamma secretase modulators: New Alzheimer’s drugs on the horizon?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7389</span>– <span class="NLM_lpage">7409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01960</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01960" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7389-7409&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=J.-F.+Blain&title=Gamma+secretase+modulators%3A+New+Alzheimer%E2%80%99s+drugs+on+the+horizon%3F&doi=10.1021%2Facs.jmedchem.5b01960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Blain, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7389-7409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The rapidly aging population desperately requires new therapies for Alzheimer's disease.  Despite years of pharmaceutical research, limited clin. success has been realized, with several failed disease modification therapies in recent years.  On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its prodn.  In this Perspective, we focus on the development of small mols. that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concn. of the shorter non-amyloidogenic Aβ species.  After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clin. proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEjGJ5oHdrrVg90H21EOLACvtfcHk0lhCgDesoN50GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D&md5=8ba1b7de2ce64903c296b7cb63c1c5d3</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DBlain%26aufirst%3DJ.-F.%26atitle%3DGamma%2520secretase%2520modulators%253A%2520New%2520Alzheimer%25E2%2580%2599s%2520drugs%2520on%2520the%2520horizon%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7389%26epage%3D7409%26doi%3D10.1021%2Facs.jmedchem.5b01960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhCgDesoN50GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lhQQDJEDQj1IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>, DOI: <span class="refDoi"> DOI: 10.1016/B978-0-12-409547-2.13809-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-Secretase%2520%2528BACE%2529%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383%26doi%3D10.1016%2FB978-0-12-409547-2.13809-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhQQDJEDQj1IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure+based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure%2520based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0li3CR4pX4cQKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstroem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soederman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundstroem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotticci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öhberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgievska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9346</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstroemauthor=S.+von+Bergauthor=P.+Soedermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstroemauthor=M.+Sundstroemauthor=D.+Turekauthor=J.+Kihlstroemauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketjaellauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+Faelting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0li3CR4pX4cQKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstroem%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DSoederman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstroem%26aufirst%3DJ.%26aulast%3DSundstroem%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstroem%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: Conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+Conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9eR"><div class="casContent"><span class="casTitleNuber">9e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lhr4sdT-CB5KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520Conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0lhr4sdT-CB5KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhchan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): Identification of (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9831</span>, <span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+Identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%B2H-spiro%5Bchromeno%5B2%2C3-b%5Dpyridine-5%2C4%E2%80%B2-oxazol%5D-2%E2%80%B2-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)</span></div><div class="casAuthors">Dineen, Thomas A.; Chen, Kui; Cheng, Alan C.; Derakhchan, Katayoun; Epstein, Oleg; Esmay, Joel; Hickman, Dean; Kreiman, Chuck E.; Marx, Isaac E.; Wahl, Robert C.; Wen, Paul H.; Weiss, Matthew M.; Whittington, Douglas A.; Wood, Stephen; Fremeau, Robert T.; White, Ryan D.; Patel, Vinod F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9811-9831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compds. exhibited potential hERG liabilities.  In this article, we describe 4-aza substitution on the xanthene core as a means to increase BACE1 potency while reducing hERG binding affinity.  Further optimization of the P3 and P2' side chains resulted in the identification of 42 (AMG-8718), a compd. with a balanced profile of BACE1 potency, hERG binding affinity, and Pgp recognition.  This compd. produced robust and sustained redns. of CSF and brain Aβ levels in a rat pharmacodynamic model and exhibited significantly reduced potential for QTc elongation in a cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDPCl7cW3IyLVg90H21EOLACvtfcHk0lhr4sdT-CB5KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrP&md5=4c586d61f5ba555948eed2c27b728fbb</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520Identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0lhQfs9WGF4Z1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.g</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.g+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lhQfs9WGF4Z1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.g%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span>; <span class="NLM_string-name">McKittrick, B.</span>; <span class="NLM_string-name">Sun, Z.-Y.</span>; <span class="NLM_string-name">Yuanzan, C.</span>; <span class="NLM_string-name">Voigt, J.
H.</span>; <span class="NLM_string-name">Strickland, C.</span>; <span class="NLM_string-name">Smith, E.
M.</span>; <span class="NLM_string-name">Stamford, A.</span>; <span class="NLM_string-name">Greenlee, W. J.</span>; <span class="NLM_string-name">Iserloh, U.</span>; <span class="NLM_string-name">Mazzola, R.</span>; <span class="NLM_string-name">Caldwell, J.</span>; <span class="NLM_string-name">Cumming, J.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Gua, T.</span>; <span class="NLM_string-name">Le, T. X. H.</span>; <span class="NLM_string-name">Saionz, K. W.</span>; <span class="NLM_string-name">Babu, S. D.</span>; <span class="NLM_string-name">Hunter, R.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Aspartyl Protease Inhibitors</span>. <span class="NLM_patent">WO2005058311 A1</span>, June 30, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=Z.+Zhu&author=B.+McKittrick&author=Z.-Y.+Sun&author=C.+Yuanzan&author=J.%0AH.+Voigt&author=C.+Strickland&author=E.%0AM.+Smith&author=A.+Stamford&author=W.+J.+Greenlee&author=U.+Iserloh&author=R.+Mazzola&author=J.+Caldwell&author=J.+Cumming&author=L.+Wang&author=T.+Gua&author=T.+X.+H.+Le&author=K.+W.+Saionz&author=S.+D.+Babu&author=R.+Hunter&title=Heterocyclic+Aspartyl+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DHeterocyclic%2520Aspartyl%2520Protease%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span>; <span class="NLM_string-name">Erdei, J. J.</span>; <span class="NLM_string-name">Gunawan, I. S.</span>; <span class="NLM_string-name">Zhou, P.</span>; <span class="NLM_string-name">Yan, Y.</span>; <span class="NLM_string-name">Quagliato, D. A.</span></span> <span> </span><span class="NLM_article-title">Amino-5,5-diphenylimidazolone Derivatives for the Inhibition of Beta-Secretase</span>. <span class="NLM_patent">US20050282825</span>, December 22, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+S.+Malamas&author=J.+J.+Erdei&author=I.+S.+Gunawan&author=P.+Zhou&author=Y.+Yan&author=D.+A.+Quagliato&title=Amino-5%2C5-diphenylimidazolone+Derivatives+for+the+Inhibition+of+Beta-Secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26atitle%3DAmino-5%252C5-diphenylimidazolone%2520Derivatives%2520for%2520the%2520Inhibition%2520of%2520Beta-Secretase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lixK1ZqZqL9pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lixK1ZqZqL9pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0ljZETVcr1P8HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=X.+Chenauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=E.+M.+Parkerauthor=A.+W.+Stamfordauthor=J.+N.+Cummingauthor=W.+Liauthor=J.+D.+Scottauthor=K.+Coxauthor=M.+F.+Dockendorfauthor=H.+J.+Kleijnauthor=H.+Meiauthor=J.+A.+Stoneauthor=M.+Eganauthor=L.+Ereshefskyauthor=S.+Jheeauthor=B.+A.+Mattsonauthor=J.+Palczaauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_label">(a) </span>Details of elenbecestat are given at Alzforum website. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details+of+elenbecestat+are+given+at+Alzforum+website.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span>The structure
of elenbecestat can be found at PubChem website. <a href="https://pubchem.ncbi.nlm.nih.gov/compound/57827330#section=Top" class="extLink">https://pubchem.ncbi.nlm.nih.gov/compound/57827330#section=Top</a> (accessed May 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+structure%0Aof+elenbecestat+can+be+found+at+PubChem+website.+https%3A%2F%2Fpubchem.ncbi.nlm.nih.gov%2Fcompound%2F57827330%23section%3DTop+%28accessed+May+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">A predicted structure of RG-7129 is given in ref <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebers&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjaell, Susanna; Janson, Juliette; Kaspersson, Karin; Bogstedt, Anna; Jeppsson, Fredrik; Faelting, Johanna; Haeberlein, Samantha Budd; Kugler, Alan R.; Alexander, Robert C.; Cebers, Gvido; Ho, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1123</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A growing body of pathol., biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in prodn., processing, and/or clearance of brain amyloid-β peptide (Aβ) concns., plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the sol. N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the prodn. of Aβ.  Here, we report the in vitro and in vivo pharmacol. profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent redns. in plasma, cerebrospinal fluid, and brain concns. of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concns. in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the obsd. effect beyond the turnover rate of Aβ.  The preclin. data strongly support the clin. development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMi27mSRG67Vg90H21EOLACvtfcHk0ljyjVFiHwQr-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D&md5=6d022dd410874469f2fce43d463bd63c</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> Details of CNP520 are given at Alzforum
Web site. <a href="http://www.alzforum.org/therapeutics/cnp520" class="extLink">http://www.alzforum.org/therapeutics/cnp520</a> (accessed September
10, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Details+of+CNP520+are+given+at+Alzforum%0AWeb+site.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fcnp520+%28accessed+September%0A10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dement. (N. Y.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=29067308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2ebrmC0Z82ESFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dement.%2520%2528N.%2520Y.%2529%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Of these seven clinical compounds, clinical studies of LY-2811376, LY-2886721, and RG-7129 were discontinued due to adverse findings observed in a preclinical 3-month rat toxicology study, abnormal liver enzyme elevations in a phase II study, and unknown reasons, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Aminodihydrothiazine Derivatives as β-Secretase Inhibitors</span>. <span class="NLM_patent">WO2007049532 A1</span>, March 5, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Aminodihydrothiazine+Derivatives+as+%CE%B2-Secretase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-Aminodihydrothiazine%2520Derivatives%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitors: A head group scan on a series of amides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4239</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+A+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0lgVXBws5gHV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520A%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lgVXBws5gHV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>Related comments can be
found in ref <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> or
at the following Web site<a href="http://www.alzforum.org/therapeutics/rg7129" class="extLink">http://www.alzforum.org/therapeutics/rg7129</a> (accessed June 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Related+comments+can+be%0Afound+in+ref+%288b%29+or%0Aat+the+following+Web+sitehttp%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Frg7129+%28accessed+June+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS Drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+Drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lg_kvzPkPoEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520Drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lg_kvzPkPoEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Most of the compounds used in the data set were described in ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>. We analyzed 70 compounds with BACE1 IC<sub>50</sub> of <100 nM and experimental p<i>K</i><sub>a</sub> values, which were submitted at the start of this research.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span> <i>ACD/Percepta</i>, version <span class="NLM_edition">14.0.0</span> (build
2726); <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Ontario, Canada</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ACD%2FPercepta%2C+version+14.0.0+%28build%0A2726%29%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Ontario%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FPercepta%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dammer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1186/s40035-015-0041-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1186%2Fs40035-015-0041-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=26448863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=18&author=Y.-B.+Huauthor=E.+B.+Dammerauthor=R.-J.+Renauthor=G.+Wang&title=The+endosomal-lysosomal+system%3A+from+acidification+and+cargo+sorting+to+neurodegeneration&doi=10.1186%2Fs40035-015-0041-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span></div><div class="casAuthors">Hu, Yong-Bo; Dammer, Eric B.; Ren, Ru-Jing; Wang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/10</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The endosomal-lysosomal system is made up of a set of intracellular membranous compartments that dynamically interconvert, which is comprised of early endosomes, recycling endosomes, late endosomes, and the lysosome.  In addn., autophagosomes execute autophagy, which delivers intracellular contents to the lysosome.  Maturation of endosomes and/or autophagosomes into a lysosome creates an unique acidic environment within the cell for proteolysis and recycling of unneeded cellular components into usable amino acids and other biomol. building blocks.  In the endocytic pathway, gradual maturation of endosomes into a lysosome and acidification of the late endosome are accompanied by vesicle trafficking, protein sorting and targeted degrdn. of some sorted cargo.  Two opposing sorting systems are operating in these processes: the endosomal sorting complex required for transport (ESCRT) supports targeted degrdn. and the retromer supports retrograde retrieval of certain cargo.  The endosomal-lysosomal system is emerging as a central player in a host of neurodegenerative diseases, demonstrating potential roles which are likely to be revealed in pathogenesis and for viable therapeutic strategies.  Here we focus on the physiol. process of endosomal-lysosomal maturation, acidification and sorting systems along the endocytic pathway, and further discuss relationships between abnormalities in the endosomal-lysosomal system and neurodegenerative diseases, esp. Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sz_jogdArVg90H21EOLACvtfcHk0lg_kvzPkPoEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D&md5=819113d11b363b56845873309c4219ef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs40035-015-0041-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-015-0041-1%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.-B.%26aulast%3DDammer%26aufirst%3DE.%2BB.%26aulast%3DRen%26aufirst%3DR.-J.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DThe%2520endosomal-lysosomal%2520system%253A%2520from%2520acidification%2520and%2520cargo%2520sorting%2520to%2520neurodegeneration%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2015%26volume%3D4%26spage%3D18%26doi%3D10.1186%2Fs40035-015-0041-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterases: structure, function and polymorphism in mammals</span>. <i>J. Pestic. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1584/jpestics.R10-02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1584%2Fjpestics.R10-02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKit7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=218-228&author=T.+Satohauthor=M.+Hosokawa&title=Carboxylesterases%3A+structure%2C+function+and+polymorphism+in+mammals&doi=10.1584%2Fjpestics.R10-02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylesterases: structure, function and polymorphism in mammals</span></div><div class="casAuthors">Satoh, Tetsuo; Hosikawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pesticide Science (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-228</span>CODEN:
                <span class="NLM_cas:coden">JPSTCF</span>;
        ISSN:<span class="NLM_cas:issn">1348-589X</span>.
    
            (<span class="NLM_cas:orgname">Pesticide Science Society of Japan</span>)
        </div><div class="casAbstract">A review.  This review covers current developments in mol.-based studies of the structure and function of carboxylesterases.  To allay the confusion of the classic classification of carboxylesterase isoenzymes, we propose a novel nomenclature and classification of mammalian carboxylesterases on the basis of mol. properties.  Mechanisms of the regulation of the gene expression of carboxylesterases by xenobiotics, and the involvement of carboxylesterase in drug metab. are also described.  The novel biomarker for organophosphate pesticide exposure developed here is much more useful and reliable than cholinesterase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8znkT2c2B9LVg90H21EOLACvtfcHk0ljEC0Kd_y4y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKit7jN&md5=956d777136501f3f5488bbd50c1d2f1c</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1584%2Fjpestics.R10-02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1584%252Fjpestics.R10-02%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DCarboxylesterases%253A%2520structure%252C%2520function%2520and%2520polymorphism%2520in%2520mammals%26jtitle%3DJ.%2520Pestic.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D218%26epage%3D228%26doi%3D10.1584%2Fjpestics.R10-02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Human Carboxylesterase Isozymes: catalytic properties and rational drug design</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.2133/dmpk.21.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.2133%2Fdmpk.21.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=16858120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Siu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=173-185&author=T.+Imai&title=Human+Carboxylesterase+Isozymes%3A+catalytic+properties+and+rational+drug+design&doi=10.2133%2Fdmpk.21.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase Isozymes: catalytic properties and rational drug design</span></div><div class="casAuthors">Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Human carboxylesterase 1 (hCE-1, CES1A1, HU1) and carboxylesterase 2 (hCE-2, hiCE, HU3) are a serine esterase involved in both drug metab. and activation.  Although both hCE-1 and hCE-2 are present in several organs, the hydrolase activity of liver and small intestine is predominantly attributed to hCE-1 and hCE-2, resp.  The substrate specificity of hCE-1 and hCE-2 is significantly different.  HCE-1 mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active pocket sometimes allows it to act on structurally distinct compds. of either large or small alc. moiety.  In contrast, hCE-2 recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by a capability of acyl-hCE-2 conjugate formation due to the presence of conformational interference in the active pocket.  Furthermore, hCE-1 shows high transesterification activity, esp. with hydrophobic alc., but negligible for hCE-2.  Transesterification may be a reason for the substrate specificity of hCE-1 that hardly hydrolyzes a substrate with hydrophobic alc. group, because transesterification can progress at the same time when a compd. is hydrolyzed by hCE-1.  From the standpoint of drug absorption, the intestinal hydrolysis by CES during drug absorption is evaluated in rat intestine and Caco2-cell line.  The rat in situ single-pass perfusion shows markedly extensive hydrolysis in the intestinal mucosa.  Since the hydrolyzed products are present at higher concn. in the epithelial cells rather than blood vessels and intestinal lumen, hydrolyzates are transported by a specific efflux transporter and passive diffusion according to pH-partition.  The expression pattern of CES in Caco-2 cell monolayer, a useful in vitro model for rapid screening of human intestinal drug absorption, is completely different from that in human small intestine but very similar to human liver that expresses a much higher level of hCE-1 and lower level of hCE-2.  Therefore, the prediction of human intestinal absorption using Caco-2 cell monolayers should be carefully monitored in the case of ester and amide-contg. drugs such as prodrugs.  Further experimentation for an understanding of detailed substrate specificity for CES and development of in vitro evaluation systems for absorption of prodrug and its hydrolyzates will help us to design the ideal prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppSsuxleoMALVg90H21EOLACvtfcHk0ljEC0Kd_y4y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Siu74%253D&md5=45b914a8c7db6e411522f202501a446d</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.173%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26atitle%3DHuman%2520Carboxylesterase%2520Isozymes%253A%2520catalytic%2520properties%2520and%2520rational%2520drug%2520design%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D173%26epage%3D185%26doi%3D10.2133%2Fdmpk.21.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">The chemical name of the aniline is (<i>S</i>)-4-(5-amino-2-fluorophenyl)-6-(fluoromethyl)-4-methyl-4<i>H</i>-1,3-oxazin-2-amine dihydrochloride.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasman, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J-.H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahematpura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.1124%2Fdmd.104.001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=15502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+C.+A.+Hopauthor=I.+N.+Kasmanauthor=J.+LaPerleauthor=J-.H.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=D.+Vanauthor=W.+Jeffreyauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+Evaluation+using+the+MDR1A%2F1B+knockout+mouse+model&doi=10.1124%2Fdmd.104.001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span></div><div class="casAuthors">Doran, Angela; Obach, R. Scott; Smith, Bill J.; Hosea, Natilie A.; Becker, Stacey; Callegari, Ernesto; Chen, Cuiping; Chen, Xi; Choo, Edna; Cianfrogna, Julie; Cox, Loretta M.; Gibbs, John P.; Gibbs, Megan A.; Hatch, Heather; Hop, Cornelis E. C. A.; Kasman, Ilana N.; LaPerle, Jennifer; Liu, JianHua; Liu, Xingrong; Logman, Michael; Maclin, Debra; Nedza, Frank M.; Nelson, Frederick; Olson, Emily; Rahematpura, Sandhya; Raunig, David; Rogers, Sabrinia; Schmidt, Kari; Spracklin, Douglas K.; Szewc, Mark; Troutman, Matthew; Tseng, Elaine; Tu, Meihua; Van Deusen, Jeffrey W.; Venkatakrishnan, Karthik; Walens, Gary; Wang, Ellen Q.; Wong, Diane; Yasgar, Adam S.; Zhang, Chenghong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two structurally diverse drugs used for the treatment of various conditions of the central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs were measured in brain, plasma, and cerebrospinal fluid in the P-glycoprotein (P-gp) knockout mouse model after s.c. administration, and the data were compared with corresponding data obtained in wild-type mice.  Total brain-to-plasma (B/P) ratios for the CNS agents ranged from 0.060 to 24.  Of the 34 CNS-active agents, only 7 demonstrated B/P area under the plasma concn. curve ratios between P-gp knockout and wild-type mice that did not differ significantly from unity.  Most of the remaining drugs demonstrated 1.1- to 2.6-fold greater B/P ratios in P-gp knockout mice vs. wild-type mice.  Three, risperidone, its active metabolite 9-hydroxyrisperidone, and metoclopramide, showed marked differences in B/P ratios between knockout and wild-type mice (6.6- to 17-fold).  Differences in B/P ratios and cerebrospinal fluid/plasma ratios between wild-type and knockout animals were correlated.  Through the use of this model, it appears that most CNS-active agents demonstrate at least some P-gp-mediated transport that can affect brain concns.  However, the impact for the majority of agents is probably minor.  The example of risperidone illustrates that even good P-gp substrates can still be clin. useful CNS-active agents.  However, for such agents, unbound plasma concns. may need to be greater than values projected using receptor affinity data to achieve adequate receptor occupancy for effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCLikZvvYtAbVg90H21EOLACvtfcHk0ljEC0Kd_y4y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D&md5=58acf489206dfeaaa96da4329e403710</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001230%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ-.H.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520Evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174%26doi%3D10.1124%2Fdmd.104.001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>The ICR
mice were obtained from Charles River Laboratories Japan, Inc., Yokohama,
Japan. <a href="http://www.crj.co.jp/product/domestic/detail/37" class="extLink">http://www.crj.co.jp/product/domestic/detail/37</a> (accessed March
4, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+ICR%0Amice+were+obtained+from+Charles+River+Laboratories+Japan%2C+Inc.%2C+Yokohama%2C%0AJapan.+http%3A%2F%2Fwww.crj.co.jp%2Fproduct%2Fdomestic%2Fdetail%2F37+%28accessed+March%0A4%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1inhibition in a dog model</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=23948925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-%CE%B2+peptides+in+cerebrospinal+fluid+after+BACE1inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model</span></div><div class="casAuthors">Borghys Herman; Jacobs Tom; Van Broeck Bianca; Dillen Lieve; Dhuyvetter Deborah; Gijsen Harrie; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beta-secretase is the first cleavage enzyme of amyloid-β protein precursor (AβPP) in the amyloidogenic pathway, leading to the formation of the plaque forming Amyloid-β (Aβ)1-42 peptide.  BACE (beta-site AβPP cleaving enzyme) 1 inhibition is therefore considered to be a promising disease modifying therapy for Alzheimer's disease.  An early assessment of the in vivo activity of BACE inhibitors was done in dogs since AβPP processing is the same as in humans and this species easily enables longitudinal cerebrospinal fluid (CSF) sampling.  Aβ changes in CSF compared to baseline are used to evaluate target engagement of the compounds.  Levels of Aβ1-37, Aβ1-38, Aβ1-40, and Aβ1-42 in CSF are measured with immunoassay (Mesoscale electrochemiluminescence technology) and with an ultra high-performance liquid chromatography mass spectrometry (UPLC-MS/MS).  Two experimental BACE inhibitors were evaluated.  With the immunoassay, a dose dependent decrease is observed for all four Aβ peptides.  Measurements with the UPLC-MS/MS are in line with the immunoassay for Aβ1-37, Aβ1-38, and Aβ1-40, however, for Aβ1-42, differences are sometimes observed when comparing to changes seen in the other peptides with UPLC-MS/MS and with immunoassay results.  Generally lower concentrations are measured with immunoassay.  The reason for these differences is still unknown.  Aβ1-42 is more prone to form aggregates compared to the other peptides.  One hypothesis could be that while the immunoassay only measures free Aβ, bound and aggregated Aβ peptides are at least partially dissolved with the UPLC-MS/MS method, since acetonitrile is added to the CSF samples.  This increases variability in the concentration of Aβ peptide measured with UPLC-MS/MS, especially for Aβ1-42, potentially masking the compound effect on Aβ1-42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMHtlzo9xastyfW6udTcc2eaTrFJ-O5Oxv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVOqug%253D%253D&md5=12cfea7618a0e7d052b1488f38548e60</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-%25CE%25B2%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Head, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarsoza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayed, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studzinski, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-1397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=10.3233%2FJAD-2010-1397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=20164551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFWjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=637-646&author=E.+Headauthor=V.+Popauthor=F.+Sarsozaauthor=R.+Kayedauthor=T.+L.+Beckettauthor=C.+M.+Studzinskiauthor=J.+L.+Tomicauthor=C.+G.+Glabeauthor=M.+P.+Murphy&title=Amyloid-%CE%B2+peptide+and+oligomers+in+the+brain+and+cerebrospinal+fluid+of+aged+canines&doi=10.3233%2FJAD-2010-1397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Peptide and Oligomers in the Brain and Cerebrospinal Fluid of Aged Canines</span></div><div class="casAuthors">Head, Elizabeth; Pop, Viorela; Sarsoza, Floyd; Kayed, Rakez; Beckett, Tina L.; Studzinski, Christa M.; Tomic, Jennifer L.; Glabe, Charles G.; Murphy, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-646</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amt. of amyloid pathol. in the brain.  Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function.  However, the type and quantity of biochem. extd. Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examd. systematically.  Thirty beagles, aged 4.5-15.7 years, were studied.  Aβ40 and Aβ42 were measured in CSF by ELISA, and from SDS and formic acid extd. prefrontal cortex.  A sample of the contralateral hemisphere, used to assess immunohistochem. amyloid load, was used for comparison.  In the brain, increases in Aβ42 were detected at a younger age, prior to increases in Aβ40, and were correlated with an increased amyloid load.  In the CSF, Aβ42 decreased with age while Aβ40 levels remained const.  The CSF Aβ42/40 ratio was also a good predictor of the amt. of Aβ in the brain.  The amt. of sol. oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS sol. Aβ42.  These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain.  These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathol. and is a potentially useful model for the refinement of therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqGuadzTdJZrVg90H21EOLACvtfcHk0liiArkJpdPjdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFWjsb8%253D&md5=c0442f9de72f8fdd88458d3da75a8dfd</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1397%26sid%3Dliteratum%253Aachs%26aulast%3DHead%26aufirst%3DE.%26aulast%3DPop%26aufirst%3DV.%26aulast%3DSarsoza%26aufirst%3DF.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DBeckett%26aufirst%3DT.%2BL.%26aulast%3DStudzinski%26aufirst%3DC.%2BM.%26aulast%3DTomic%26aufirst%3DJ.%2BL.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DAmyloid-%25CE%25B2%2520peptide%2520and%2520oligomers%2520in%2520the%2520brain%2520and%2520cerebrospinal%2520fluid%2520of%2520aged%2520canines%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D637%26epage%3D646%26doi%3D10.3233%2FJAD-2010-1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">The tert-butanesulfinyl group: an ideal chiral directing group and Boc-surrogate for the asymmetric synthesis and applications of β-amino acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1021/jo9820824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9820824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaK1cXotVCrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=12-13&author=T.+P.+Tangauthor=J.+A.+Ellman&title=The+tert-butanesulfinyl+group%3A+an+ideal+chiral+directing+group+and+Boc-surrogate+for+the+asymmetric+synthesis+and+applications+of+%CE%B2-amino+acids&doi=10.1021%2Fjo9820824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-Butanesulfinyl Group: An Ideal Chiral Directing Group and Boc-Surrogate for the Asymmetric Synthesis and Applications of β-Amino Acids</span></div><div class="casAuthors">Tang, Tony P.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-13</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The utility of tert-butanesulfinamide [i.e., [S(R)]-2-methyl-2-propanesulfinamide derivs.] in the chiral synthesis of β-amino acids was demonstrated.  The condensation of [S(R)]-2-methyl-2-propanesulfinamide with carbonyl compds. gave the corresponding sulfinyl imines.  The diastereofacial selectivity of these imines toward lithium or titanium enolate addn. was studied.  One of the compds. thus prepd. was converted into (-)-N-[N-[[[4-(aminoiminomethyl)phenyl]amino]carbonyl]-3-(3-pyridinyl)-β-alanyl]-β-alanine Et ester, which is a precursor for a known GPIIbIIIa antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9TX5d-94zObVg90H21EOLACvtfcHk0liiArkJpdPjdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVCrsrk%253D&md5=76a1845d086069a408d2027c68c1321a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjo9820824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9820824%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520tert-butanesulfinyl%2520group%253A%2520an%2520ideal%2520chiral%2520directing%2520group%2520and%2520Boc-surrogate%2520for%2520the%2520asymmetric%2520synthesis%2520and%2520applications%2520of%2520%25CE%25B2-amino%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D12%26epage%3D13%26doi%3D10.1021%2Fjo9820824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, E. M.</span></span> <span> </span><span class="NLM_article-title">The reactions of an N-sulfonylamine inner salt</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">4744</span>– <span class="NLM_lpage">4745</span>, <span class="refDoi"> DOI: 10.1021/ja01019a052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01019a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;key=1%3ACAS%3A528%3ADyaF1cXltVKlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=4744-4745&author=G.+M.+Atkinsauthor=E.+M.+Burgess&title=The+reactions+of+an+N-sulfonylamine+inner+salt&doi=10.1021%2Fja01019a052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The reactions of an N-sulfonylamine inner salt</span></div><div class="casAuthors">Atkins, George M., Jr.; Burgess, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4744-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Cryst. ethyl(carboxysulfamoyl)triethylammonium hydroxide, EtO2CN-SO2N+Et3 (I), was prepd. by treating Et2OCNHSO2Cl with Et3N in C6H6 and the various reactions of I were studied.  Treating a C6H6 soln. of I with PhNH2, 2-propanol, or PhNMe2 yielded EtO2CNHSO2NHPh, EtO2CNHSO2OCHMe2, or N,N-dimethyl-N'-carbethoxysulfanilamide, resp.  The electrophilic addn. of I to N-vinylpyrolidinone yielded N-(2-carbethoxyamidosulfonylvinyl)pyrrolidone.  Treating I in MeCN with tetramethylallene yielded a 5-1 mixt. of 2,3-dihydro-2,2-dimethyl-3-isopropylidene-6-ethoxy-1,4,5-oxathiazine 4,4-dioxide and 2-carbethoxy-3,3-dimethyl-4-isopropylidene-1,2-thiazetidine 1,1-dioxide.  Treating I with hexamethylbicyclo[2.2.0]hexa-2,5-diene yielded the 1-1 cycloadduct II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcfVN2fKPhrVg90H21EOLACvtfcHk0lhTXHssL_Xugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXltVKlurw%253D&md5=748b54624f45f4da1cac6037c91b7f27</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja01019a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01019a052%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DG.%2BM.%26aulast%3DBurgess%26aufirst%3DE.%2BM.%26atitle%3DThe%2520reactions%2520of%2520an%2520N-sulfonylamine%2520inner%2520salt%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D4744%26epage%3D4745%26doi%3D10.1021%2Fja01019a052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY','PDB','5YGY'); return false;">PDB: 5YGY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00002">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86140"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00002">10.1021/acs.jmedchem.8b00002</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figure S1, experimental procedures, and characterization data for compounds <b>12</b>–<b>14</b>, <b>16</b>–<b>18</b> and the carboxylic acids for <b>25</b> and <b>26</b>, crystallographic information, methods for biological, DMPK, physicochemical, and toxicological assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILE strings, BACE1 IC<sub>50</sub>, cellular Aβ IC<sub>50</sub>, P-gp ER, hERG % inhibition at 5 μM, log <i>D</i>, p<i>K</i><sub>a</sub>, % remaining in HLM, and % remaining in RLM (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_001.pdf">jm8b00002_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00002/suppl_file/jm8b00002_si_002.csv">jm8b00002_si_002.csv (1.96 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray structure of <b>15</b> bound to human BACE1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YGY">5YGY</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00002%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00002" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799184a6d8a3c0a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
